Induction	O
of	O
relA	B-protein
(	I-protein
p65	I-protein
)	I-protein
and	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
subunit	I-protein
expression	O
during	O
differentiation	O
of	O
human	B-cell_type
peripheral	I-cell_type
blood	I-cell_type
monocytes	I-cell_type
to	O
macrophages	B-cell_type
.	O

We	O
evaluated	O
the	O
expression	O
and	O
DNA	O
binding	O
activity	O
of	O
nuclear	B-protein
factor	I-protein
(	I-protein
NF	I-protein
)	I-protein
-kappa	I-protein
B	I-protein
subunits	I-protein
in	O
human	B-cell_type
peripheral	I-cell_type
blood	I-cell_type
monocytes	I-cell_type
and	O
in	O
monocyte-derived	B-cell_type
macrophages	I-cell_type
(	O
MDMs	B-cell_type
)	O
.	O

Constitutive	O
DNA	O
binding	O
activity	O
consisting	O
of	O
p50	B-protein
homodimers	I-protein
was	O
detected	O
in	O
nuclear	O
extracts	O
from	O
both	O
cell	O
types	O
.	O

An	O
additional	O
complex	O
composed	O
of	O
p50/RelA	B-protein
(	I-protein
p65	I-protein
)	I-protein
heterodimers	I-protein
appeared	O
only	O
in	O
nuclear	O
extracts	O
from	O
7-day	O
MDMs	B-cell_type
.	O

Immunoblot	O
analysis	O
showed	O
that	O
the	O
p50	O
subunit	O
was	O
constitutively	O
expressed	O
in	O
monocytes	B-cell_type
and	O
MDMs	B-cell_type
.	O

In	O
contrast	O
,	O
the	O
RelA	B-protein
(	I-protein
p65	I-protein
)	I-protein
subunit	I-protein
was	O
barely	O
detectable	O
in	O
monocytes	B-cell_type
,	O
but	O
its	O
level	O
increased	O
markedly	O
in	O
MDMs	B-cell_type
.	O

Analysis	O
of	O
RelA	B-RNA
(	I-RNA
p65	I-RNA
)	I-RNA
mRNA	I-RNA
revealed	O
that	O
the	O
stability	O
of	O
RelA	B-RNA
(	I-RNA
p65	I-RNA
)	I-RNA
mRNA	I-RNA
was	O
significantly	O
higher	O
in	O
MDMs	B-cell_type
,	O
compared	O
with	O
monocytes	B-cell_type
.	O

In	O
MDMs	B-cell_type
,	O
an	O
upregulation	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
synthesis	O
as	O
well	O
as	O
the	O
appearance	O
of	O
a	O
novel	O
M	O
(	O
r	O
)	O
40	O
,	O
000	O
form	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
were	O
also	O
observed	O
.	O

These	O
results	O
suggest	O
that	O
macrophage	O
differentiation	O
results	O
in	O
the	O
expression	O
of	O
active	O
p50/RelA	B-protein
(	I-protein
p65	I-protein
)	I-protein
heterodimers	I-protein
with	O
the	O
capacity	O
to	O
activate	O
target	O
gene	O
expression	O
.	O

The	O
parallel	O
induction	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
synthesis	O
may	O
allow	O
for	O
the	O
continuous	O
presence	O
of	O
a	O
cytoplasmic	O
reservoir	O
of	O
p50/RelA	B-protein
(	I-protein
p65	I-protein
)	I-protein
complexes	I-protein
that	O
are	O
readily	O
available	O
for	O
inducer-mediated	O
stimulation	O
.	O

Vol	NULL
.	NULL

8	NULL
,	NULL
435-442	NULL
,	NULL
April	NULL
1997	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
Induction	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
and	NULL
IxBa	NULL
Subunit	NULL
Expression	NULL
during	NULL
Differentiation	NULL
of	NULL
Human	NULL
Peripheral	NULL
Blood	NULL
Monocytes	NULL
to	NULL
Macrophages	NULL
'	NULL
Lucia	NULL
Conti	NULL
,	NULL
John	NULL
Hiscott	NULL
,	NULL
Maddalena	NULL
Papacchini	NULL
,	NULL
Anne	NULL
Roulston	NULL
,	NULL
Mark	NULL
A.	NULL
Wainberg	NULL
,	NULL
Filippo	NULL
Belardelli	NULL
,	NULL
and	NULL
Sandra	NULL
Gessani*	NULL
Laboratory	NULL
of	NULL
Virology	NULL
,	NULL
Istituto	NULL
Superiore	NULL
di	NULL
Sanita	NULL
,	NULL
Viale	NULL
Regina	NULL
Elena	NULL
299	NULL
,	NULL
00161	NULL
Rome	NULL
,	NULL
Italy	NULL
[	NULL
L.	NULL
C.	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
F.	NULL
B.	NULL
,	NULL
S.	NULL
G.	NULL
]	NULL
,	NULL
and	NULL
Lady	NULL
Davis	NULL
Institute	NULL
for	NULL
Medical	NULL
Research	NULL
,	NULL
McGill	NULL
AIDS	NULL
Center	NULL
,	NULL
McGill	NULL
University	NULL
,	NULL
Montreal	NULL
,	NULL
Quebec	NULL
,	NULL
H3T	NULL
1E2	NULL
Canada	NULL
[	NULL
J.	NULL
H.	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
M.	NULL
A.	NULL
W.	NULL
]	NULL
Abstract	NULL
We	NULL
evaluated	NULL
the	NULL
expression	NULL
and	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
nuclear	NULL
factor	NULL
(	NULL
NF	NULL
)	NULL
-	NULL
«	NULL
B	NULL
subunits	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
and	NULL
in	NULL
monocyte-derived	NULL
macrophages	NULL
(	NULL
MDMs	NULL
)	NULL
.	NULL

Constitutive	NULL
DNA	NULL
binding	NULL
activity	NULL
consisting	NULL
of	NULL
p50	NULL
homodimers	NULL
was	NULL
detected	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
both	NULL
cell	NULL
types	NULL
.	NULL

An	NULL
additional	NULL
complex	NULL
composed	NULL
of	NULL
p50/RelA	NULL
(	NULL
p65	NULL
)	NULL
heterodimers	NULL
appeared	NULL
only	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
7-day	NULL
MDMs	NULL
.	NULL

Immunoblot	NULL
analysis	NULL
showed	NULL
that	NULL
the	NULL
p50	NULL
subunit	NULL
was	NULL
constitutively	NULL
expressed	NULL
in	NULL
monocytes	NULL
and	NULL
MDMs	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
subunit	NULL
was	NULL
barely	NULL
detectable	NULL
in	NULL
monocytes	NULL
,	NULL
but	NULL
its	NULL
level	NULL
increased	NULL
markedly	NULL
in	NULL
MDMs	NULL
.	NULL

Analysis	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
mRNA	NULL
revealed	NULL
that	NULL
the	NULL
stability	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
mRNA	NULL
was	NULL
significantly	NULL
higher	NULL
in	NULL
MDMs	NULL
,	NULL
compared	NULL
with	NULL
monocytes	NULL
.	NULL

In	NULL
MDMs	NULL
,	NULL
an	NULL
up-regulation	NULL
of	NULL
IxBa	NULL
synthesis	NULL
as	NULL
well	NULL
as	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
novel	NULL
M	NULL
,	NULL
40,000	NULL
form	NULL
of	NULL
I	NULL
«	NULL
Ba	NULL
were	NULL
also	NULL
observed	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
macrophage	NULL
differentiation	NULL
results	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
active	NULL
p50/RelA	NULL
(	NULL
p65	NULL
)	NULL
heterodimers	NULL
with	NULL
the	NULL
capacity	NULL
to	NULL
activate	NULL
target	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
parallel	NULL
induction	NULL
of	NULL
IkBa	NULL
synthesis	NULL
may	NULL
allow	NULL
for	NULL
the	NULL
continuous	NULL
presence	NULL
of	NULL
a	NULL
cytoplasmic	NULL
reservoir	NULL
of	NULL
p50/RelA	NULL
(	NULL
p65	NULL
)	NULL
complexes	NULL
that	NULL
are	NULL
readily	NULL
available	NULL
for	NULL
inducer-mediated	NULL
stimulation	NULL
.	NULL

Introduction	NULL
The	NULL
NF®-	NULL
«	NULL
B/Rel	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
genes	NULL
important	NULL
in	NULL
the	NULL
Received	NULL
5/30/96	NULL
;	NULL
revised	NULL
6/30/96	NULL
;	NULL
accepted	NULL
11/12/97	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solety	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

'This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Grant	NULL
940C	NULL
,	NULL
Xl	NULL
Progetto	NULL
di	NULL
Ricerca	NULL
sull'AIDS	NULL
,	NULL
from	NULL
the	NULL
Italian	NULL
Ministry	NULL
of	NULL
Health	NULL
and	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Cancer	NULL
Research	NULL
Society	NULL
,	NULL
Inc.	NULL
and	NULL
the	NULL
Medical	NULL
Research	NULL
Council	NULL
of	NULL
Canada	NULL
(	NULL
to	NULL
J.	NULL
H.	NULL
and	NULL
M.	NULL
A.	NULL
W.	NULL
)	NULL
.	NULL

A.	NULL
R.	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
studentship	NULL
from	NULL
FCAR	NULL
.	NULL

M.	NULL
P.	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
fellowship	NULL
from	NULL
the	NULL
Italian	NULL
Ministry	NULL
of	NULL
Health	NULL
.	NULL

*	NULL
To	NULL
whom	NULL
requests	NULL
for	NULL
reprints	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
396	NULL
)	NULL
49903238	NULL
;	NULL
Fax	NULL
:	NULL
(	NULL
396	NULL
)	NULL
4453369-49902082	NULL
.	NULL

®	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
nuclear	NULL
factor-	NULL
«	NULL
B	NULL
;	NULL
GAPDH	NULL
,	NULL
glycer-aldehyde-3-phosphate	NULL
dehydrogenase	NULL
;	NULL
MDM	NULL
,	NULL
monocyte-derived	NULL
macro-phage	NULL
;	NULL
RT-PCR	NULL
,	NULL
reverse	NULL
transcription-PCR	NULL
;	NULL
TfR	NULL
,	NULL
transferrin	NULL
receptor	NULL
;	NULL
WCE	NULL
,	NULL
whole-cell	NULL
extract	NULL
;	NULL
LPS	NULL
,	NULL
lipopolysaccharide	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-my-ristate	NULL
13-acetate	NULL
;	NULL
TNF	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
;	NULL
IL	NULL
,	NULL
interleukin	NULL
.	NULL

regulation	NULL
of	NULL
immune	NULL
functions	NULL
including	NULL
cytokines	NULL
,	NULL
cell	NULL
surface	NULL
immunoreceptors	NULL
,	NULL
adhesion	NULL
molecules	NULL
,	NULL
and	NULL
acute	NULL
phase	NULL
proteins	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Several	NULL
viral	NULL
enhancers	NULL
also	NULL
contain	NULL
NF-	NULL
«	NULL
B	NULL
recognition	NULL
sites	NULL
in	NULL
their	NULL
promoter	NULL
elements	NULL
and	NULL
use	NULL
this	NULL
host-regulatory	NULL
pathway	NULL
to	NULL
selectively	NULL
activate	NULL
viral	NULL
gene	NULL
expression	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

family	NULL
includes	NULL
several	NULL
members	NULL
:	NULL
p50	NULL
(	NULL
NF-	NULL
«	NULL
B1	NULL
)	NULL
and	NULL
its	NULL
precursor	NULL
p105	NULL
,	NULL
p52	NULL
(	NULL
NF-B2	NULL
)	NULL
and	NULL
its	NULL
precursor	NULL
p100	NULL
(	NULL
also	NULL
called	NULL
lyt-10	NULL
)	NULL
,	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
,	NULL
c-Rel	NULL
(	NULL
p85	NULL
)	NULL
,	NULL
and	NULL
ReIB	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
an	NULL
alternatively	NULL
spliced	NULL
form	NULL
of	NULL
RelA	NULL
,	NULL
termed	NULL
A	NULL
RelA	NULL
(	NULL
p6S5A	NULL
)	NULL
was	NULL
also	NULL
identified	NULL
(	NULL
3	NULL
)	NULL
.	NULL

All	NULL
DNA-binding	NULL
subunits	NULL
[	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
,	NULL
c-Rel	NULL
,	NULL
and	NULL
RelB	NULL
]	NULL
exhibit	NULL
extensive	NULL
homology	NULL
in	NULL
the	NULL
NH	NULL
;	NULL
-terminal	NULL
300	NULL
amino	NULL
acids	NULL
,	NULL
a	NULL
region	NULL
that	NULL
contains	NULL
DNA	NULL
binding	NULL
,	NULL
dimerization	NULL
,	NULL
and	NULL
nuclear	NULL
localization	NULL
domains	NULL
of	NULL
the	NULL
protein	NULL
(	NULL
4	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
and	NULL
c-Rel	NULL
also	NULL
contain	NULL
a	NULL
strong	NULL
transcriptional	NULL
activation	NULL
region	NULL
in	NULL
the	NULL
COOH-terminal	NULL
domain	NULL
of	NULL
the	NULL
protein	NULL
(	NULL
5	NULL
)	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
is	NULL
finely	NULL
controlled	NULL
at	NULL
multiple	NULL
regulatory	NULL
levels	NULL
including	NULL
intracellular	NULL
localization	NULL
,	NULL
posttranslational	NULL
processing	NULL
,	NULL
splicing	NULL
,	NULL
and	NULL
transcription	NULL
(	NULL
6	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
heterodimers	NULL
are	NULL
generally	NULL
retained	NULL
in	NULL
an	NULL
inactive	NULL
form	NULL
in	NULL
the	NULL
cytoplasm	NULL
through	NULL
their	NULL
interaction	NULL
with	NULL
a	NULL
group	NULL
of	NULL
inhibitory	NULL
molecules	NULL
,	NULL
the	NULL
IkBs	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Several	NULL
forms	NULL
of	NULL
IB	NULL
,	NULL
including	NULL
IxBa/MAD-3	NULL
(	NULL
and	NULL
its	NULL
avian	NULL
homologue	NULL
,	NULL
pp40	NULL
)	NULL
,	NULL
IkBB	NULL
,	NULL
bel-3	NULL
,	NULL
and	NULL
IkBy	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
p105	NULL
precursor	NULL
,	NULL
have	NULL
now	NULL
been	NULL
described	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Among	NULL
these	NULL
IB	NULL
family	NULL
members	NULL
,	NULL
IkBa	NULL
is	NULL
best	NULL
characterized	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
and	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
high	NULL
affinity	NULL
with	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
and	NULL
c-Rel	NULL
and	NULL
to	NULL
inhibit	NULL
p50/RelA	NULL
(	NULL
p65	NULL
)	NULL
and	NULL
p52/ReIA	NULL
(	NULL
p65	NULL
)	NULL
heterodimers	NULL
,	NULL
Re-IA	NULL
(	NULL
p65	NULL
)	NULL
homodimers	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
dimers	NULL
that	NULL
contain	NULL
c-Rel	NULL
(	NULL
7	NULL
,	NULL
10	NULL
)	NULL
.	NULL

In	NULL
many	NULL
cell	NULL
types	NULL
,	NULL
specific	NULL
signals	NULL
such	NULL
as	NULL
cytokines	NULL
,	NULL
phorbol	NULL
esters	NULL
,	NULL
virus	NULL
infection	NULL
,	NULL
and	NULL
mitogens	NULL
induce	NULL
the	NULL
release	NULL
of	NULL
IxBa	NULL
from	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
therefore	NULL
permitting	NULL
transport	NULL
of	NULL
DNA-binding	NULL
NF-	NULL
«	NULL
B	NULL
dimers	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
7	NULL
,	NULL
11	NULL
,	NULL
12	NULL
)	NULL
.	NULL

Phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IxBa	NULL
are	NULL
the	NULL
necessary	NULL
steps	NULL
required	NULL
for	NULL
dissociation	NULL
of	NULL
the	NULL
heterotrimeric	NULL
form	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
11	NULL
,	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
NF-kB	NULL
DNA	NULL
binding	NULL
activity	NULL
stimulates	NULL
the	NULL
de	NULL
novo	NULL
synthesis	NULL
of	NULL
IxBa	NULL
because	NULL
the	NULL
promoter	NULL
of	NULL
IkxBa	NULL
contains	NULL
NF-kB	NULL
sites	NULL
and	NULL
is	NULL
highly	NULL
responsive	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
(	NULL
15-18	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
an	NULL
auto-regulatory	NULL
loop	NULL
is	NULL
established	NULL
that	NULL
ultimately	NULL
permits	NULL
the	NULL
restoration	NULL
of	NULL
latent	NULL
NF-	NULL
«	NULL
B/I	NULL
«	NULL
Ba	NULL
complexes	NULL
in	NULL
the	NULL
cytoplasm	NULL
(	NULL
15-18	NULL
)	NULL
.	NULL

Notably	NULL
,	NULL
disruption	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/IkBa	NULL
autoregula-tory	NULL
loop	NULL
by	NULL
overexpression	NULL
of	NULL
I	NULL
«	NULL
Ba	NULL
antisense	NULL
RNA	NULL
results	NULL
in	NULL
malignant	NULL
transformation	NULL
,	NULL
suggesting	NULL
that	NULL
IxBa	NULL
may	NULL
represent	NULL
a	NULL
potential	NULL
growth-suppressor	NULL
activity	NULL
(	NULL
19	NULL
)	NULL
.	NULL

NF-kB	NULL
binding	NULL
activity	NULL
is	NULL
regulated	NULL
during	NULL
B-cell	NULL
differentiation	NULL
(	NULL
20	NULL
)	NULL
.	NULL

In	NULL
pre-B	NULL
cells	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
are	NULL
maintained	NULL
in	NULL
an	NULL
inactive	NULL
form	NULL
in	NULL
the	NULL
cytosol	NULL
,	NULL
whereas	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
is	NULL
constitutively	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
mature	NULL
B	NULL
cells	NULL
.	NULL

During	NULL
the	NULL
pre-B	NULL
cell	NULL
to	NULL
B-cell	NULL
transition	NULL
,	NULL
mod	NULL
436	NULL
-	NULL
NF-	NULL
«	NULL
B	NULL
Expression	NULL
in	NULL
Differentiating	NULL
Monocytes	NULL
Table	NULL
1	NULL
-	NULL
Evaluation	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
differentiation	NULL
markers	NULL
on	NULL
monocytes	NULL
after	NULL
different	NULL
times	NULL
of	NULL
in	NULL
vitro	NULL
culture	NULL
Values	NULL
are	NULL
expressed	NULL
as	NULL
specific	NULL
com	NULL
and	NULL
are	NULL
the	NULL
mean	NULL
of	NULL
duplicate	NULL
samples	NULL
.	NULL

SD	NULL
did	NULL
not	NULL
exceed	NULL
10	NULL
%	NULL
.	NULL

Days	NULL
in	NULL
culture	NULL
Antigens	NULL
9	NULL
1	NULL
3	NULL
7	NULL
TTR	NULL
408	NULL
2,520	NULL
11,400	NULL
CD14	NULL
1,800	NULL
4,108	NULL
9,260	NULL
CD11b	NULL
860	NULL
2,270	NULL
5,115	NULL
ulation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
occurs	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
differentia-tion-dependent	NULL
shift	NULL
from	NULL
predominantly	NULL
pS50/Re	NULL
!	NULL

A	NULL
(	NULL
p65	NULL
)	NULL
heterodimers	NULL
in	NULL
differentiating	NULL
B	NULL
cells	NULL
to	NULL
mainly	NULL
p50/c-Rel	NULL
heterodimers	NULL
in	NULL
mature	NULL
B	NULL
cells	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Constitutive	NULL
NF-	NULL
«	NULL
B/Rel	NULL
binding	NULL
activity	NULL
has	NULL
been	NULL
demonstrated	NULL
in	NULL
mature	NULL
macrophages	NULL
(	NULL
21-24	NULL
)	NULL
,	NULL
whereas	NULL
other	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
can	NULL
be	NULL
induced	NULL
during	NULL
differentiation	NULL
of	NULL
monocytic	NULL
cell	NULL
lines	NULL
stimulated	NULL
by	NULL
PMA	NULL
(	NULL
21	NULL
,	NULL
25-28	NULL
)	NULL
.	NULL

However	NULL
,	NULL
no	NULL
information	NULL
is	NULL
yet	NULL
available	NULL
on	NULL
the	NULL
pattern	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
expression	NULL
during	NULL
the	NULL
spontaneous	NULL
differentiation	NULL
of	NULL
primary	NULL
monocytes	NULL
to	NULL
macrophages	NULL
in	NULL
vitro	NULL
.	NULL

Culturing	NULL
of	NULL
freshly	NULL
isolated	NULL
human	NULL
monocytes	NULL
results	NULL
in	NULL
a	NULL
time-dependent	NULL
maturation	NULL
to	NULL
macrophages	NULL
characterized	NULL
by	NULL
an	NULL
increased	NULL
expression	NULL
of	NULL
specific	NULL
surface	NULL
markers	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
CD11/CD18	NULL
,	NULL
CD14	NULL
,	NULL
transferrin	NULL
receptor	NULL
,	NULL
ICAM-1	NULL
,	NULL
and	NULL
HLA-DR	NULL
;	NULL
Refs	NULL
.	NULL

29-31	NULL
)	NULL
as	NULL
well	NULL
as	NULL
by	NULL
an	NULL
enhanced	NULL
expression	NULL
of	NULL
some	NULL
cytokines	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
TNF-a	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
IFN-	NULL
)	NULL
in	NULL
response	NULL
to	NULL
LPS	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
most	NULL
of	NULL
these	NULL
genes	NULL
(	NULL
CD11/CD18	NULL
,	NULL
ICAM-1	NULL
,	NULL
HLA-DR	NULL
,	NULL
TNF-a	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
IFN-	NULL
$	NULL
B	NULL
)	NULL
that	NULL
play	NULL
important	NULL
roles	NULL
in	NULL
macrophage-mediated	NULL
immune	NULL
regulation	NULL
share	NULL
«	NULL
B-like	NULL
sequences	NULL
in	NULL
their	NULL
promoters	NULL
(	NULL
1	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
characterized	NULL
the	NULL
nature	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
in	NULL
human	NULL
monocytes	NULL
during	NULL
in	NULL
vitro	NULL
differentiation	NULL
.	NULL

We	NULL
report	NULL
here	NULL
that	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
strong	NULL
trans-activating	NULL
subunit	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
in	NULL
the	NULL
nucleus	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
acquisition	NULL
of	NULL
a	NULL
fully	NULL
differentiated	NULL
macrophage	NULL
phenotype	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
the	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
subunit	NULL
is	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
posttranscriptionally	NULL
regulated	NULL
.	NULL

We	NULL
also	NULL
show	NULL
that	NULL
macrophage	NULL
differentiation	NULL
is	NULL
accompanied	NULL
by	NULL
a	NULL
concomitant	NULL
increase	NULL
in	NULL
the	NULL
level	NULL
of	NULL
IkBa	NULL
,	NULL
which	NULL
may	NULL
generate	NULL
a	NULL
reservoir	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
that	NULL
can	NULL
be	NULL
readily	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
inducer-mediated	NULL
stimuli	NULL
.	NULL

Results	NULL
Evaluation	NULL
of	NULL
the	NULL
Expression	NULL
of	NULL
Differentiation	NULL
Markers	NULL
on	NULL
Cultured	NULL
Monocytes	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
surface	NULL
antigens	NULL
was	NULL
determined	NULL
after	NULL
1	NULL
,	NULL
3	NULL
,	NULL
and	NULL
7	NULL
days	NULL
of	NULL
in	NULL
vitro	NULL
culture	NULL
.	NULL

Table	NULL
1	NULL
illustrates	NULL
the	NULL
results	NULL
of	NULL
representative	NULL
experiments	NULL
evaluating	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
transferrin	NULL
receptor	NULL
(	NULL
TTR	NULL
)	NULL
,	NULL
CD14	NULL
,	NULL
and	NULL
CD11b	NULL
antigens	NULL
.	NULL

A	NULL
significant	NULL
increase	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
these	NULL
macrophage-associated	NULL
antigens	NULL
was	NULL
observed	NULL
consistently	NULL
after	NULL
3-7	NULL
days	NULL
of	NULL
culture	NULL
,	NULL
indicating	NULL
a	NULL
well-defined	NULL
,	NULL
time-dependent	NULL
differentiation	NULL
of	NULL
monocytes	NULL
to	NULL
macrophages	NULL
.	NULL

Analysis	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
Binding	NULL
Activity	NULL
in	NULL
Freshly	NULL
Isolated	NULL
Monocytes	NULL
and	NULL
7-day	NULL
Cultured	NULL
Macrophages	NULL
.	NULL

To	NULL
evaluate	NULL
whether	NULL
quantitative	NULL
or	NULL
qualitative	NULL
changes	NULL
in	NULL
the	NULL
DNA	NULL
Day	NULL
1	NULL
Day	NULL
7	NULL
I	NULL
+	NULL
,	NULL
+I	NULL
.	NULL

+	NULL
J	NULL
to	NULL
J	NULL
Competitor	NULL
|	NULL
z	NULL
E	NULL
I	NULL
3	NULL
E	NULL
«	NULL
s-	NULL
free	NULL
probe	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

-	NULL
Mobility	NULL
shift	NULL
analysis	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
proteins	NULL
in	NULL
1-day	NULL
cultured	NULL
monocytes	NULL
(	NULL
Lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
and	NULL
7-day	NULL
MDMs	NULL
(	NULL
Lanes	NULL
4-6	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
6	NULL
ug	NULL
)	NULL
were	NULL
analyzed	NULL
for	NULL
NF-kB	NULL
binding	NULL
activity	NULL
by	NULL
using	NULL
the	NULL
HIV	NULL
enhancer	NULL
oligonucleotide	NULL
(	NULL
0.2	NULL
ng	NULL
)	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

The	NULL
protein-DNA	NULL
complexes	NULL
present	NULL
in	NULL
the	NULL
extracts	NULL
were	NULL
competed	NULL
using	NULL
a	NULL
200-fold	NULL
excess	NULL
of	NULL
either	NULL
wild-type	NULL
(	NULL
wt	NULL
;	NULL
Lanes	NULL
2	NULL
and	NULL
5	NULL
)	NULL
or	NULL
mutant	NULL
{	NULL
mut	NULL
)	NULL
unlabeled	NULL
oligonucleotide	NULL
(	NULL
Lanes	NULL
3	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Arrows	NULL
,	NULL
position	NULL
of	NULL
the	NULL
retarded	NULL
bands	NULL
.	NULL

binding	NULL
properties	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
occurred	NULL
in	NULL
monocytes	NULL
during	NULL
the	NULL
course	NULL
of	NULL
their	NULL
in	NULL
vitro	NULL
differentiation	NULL
to	NULL
macrophages	NULL
,	NULL
gel	NULL
retardation	NULL
assays	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
monocytes	NULL
at	NULL
different	NULL
stages	NULL
of	NULL
differentiation	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
a	NULL
constitutive	NULL
NF-kB	NULL
binding	NULL
activity	NULL
was	NULL
present	NULL
in	NULL
both	NULL
monocytes	NULL
and	NULL
macrophages	NULL
{	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
complex	NULL
A	NULL
,	NULL
Lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
.	NULL

In	NULL
nuclear	NULL
extracts	NULL
from	NULL
7-day	NULL
cultured	NULL
monocytes	NULL
,	NULL
we	NULL
observed	NULL
the	NULL
appearance	NULL
of	NULL
an	NULL
additional	NULL
complex	NULL
incompletely	NULL
separated	NULL
from	NULL
complex	NULL
A	NULL
.	NULL

This	NULL
additional	NULL
complex	NULL
had	NULL
a	NULL
lower	NULL
electrophoretic	NULL
mobility	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
complex	NULL
B	NULL
,	NULL
Lane	NULL
4	NULL
)	NULL
.	NULL

An	NULL
excess	NULL
of	NULL
unlabeled	NULL
wild-type	NULL
oligonucleotide	NULL
was	NULL
capable	NULL
of	NULL
competing	NULL
efficiently	NULL
for	NULL
the	NULL
formation	NULL
of	NULL
these	NULL
complexes	NULL
,	NULL
whereas	NULL
a	NULL
mutated	NULL
kB	NULL
oligonucleotide	NULL
was	NULL
unable	NULL
to	NULL
block	NULL
NF-kB	NULL
binding	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
Lanes	NULL
2	NULL
,	NULL
3	NULL
,	NULL
5	NULL
,	NULL
and	NULL
6	NULL
)	NULL
,	NULL
thereby	NULL
confirming	NULL
the	NULL
specificity	NULL
of	NULL
both	NULL
complexes	NULL
.	NULL

Virtually	NULL
identical	NULL
results	NULL
were	NULL
obtained	NULL
using	NULL
1-	NULL
and	NULL
7-day	NULL
monocyte/macro-phage	NULL
cultures	NULL
from	NULL
five	NULL
different	NULL
donors	NULL
.	NULL

The	NULL
appearance	NULL
of	NULL
complex	NULL
B	NULL
was	NULL
already	NULL
observed	NULL
after	NULL
3	NULL
days	NULL
of	NULL
in	NULL
vitro	NULL
culture	NULL
of	NULL
monocytes/macrophages	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Characterization	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
Subunits	NULL
Participating	NULL
in	NULL
the	NULL
Formation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
Complexes	NULL
.	NULL

Polyclonal	NULL
antisera	NULL
specific	NULL
for	NULL
unique	NULL
sequences	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
were	NULL
used	NULL
to	NULL
identify	NULL
the	NULL
NF-kB	NULL
proteins	NULL
participating	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
complexes	NULL
A	NULL
and	NULL
B.	NULL
Antibodies	NULL
against	NULL
NF-	NULL
«	NULL
B1	NULL
(	NULL
p105/p50	NULL
)	NULL
,	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
«	NULL
~	NULL
o	NULL
Antisera	NULL
®	NULL
§	NULL
o	NULL
bes	NULL
a	NULL
&	NULL
&	NULL
3	NULL
Peptide	NULL
-o-	NULL
$	NULL
0	NULL
-	NULL
#	NULL
o-	NULL
o	NULL
$	NULL
o	NULL
-	NULL
#	NULL
01m	NULL
!	NULL

<	NULL
-	NULL
free	NULL
probe	NULL
1	NULL
2	NULL
3	NULL
4	NULL
506	NULL
7	NULL
8	NULL
9g	NULL
10	NULL
.	NULL

<	NULL
~	NULL
o	NULL
ntisera	NULL
B	NULL
©	NULL
het	NULL
A	NULL
8	NULL
B	NULL
$	NULL
<	NULL
m-+	NULL
--	NULL
+~-+	NULL
--	NULL
47	NULL
Peptide	NULL
=-	NULL
-	NULL
t	NULL
-	NULL
t	NULL
-	NULL
<	NULL
4	NULL
-	NULL
+	NULL
u	NULL
tnd	NULL
&	NULL
¢	NULL
«	NULL
s-	NULL
free	NULL
probe	NULL
1	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
9	NULL
Fig	NULL
.	NULL

2.	NULL
identification	NULL
of	NULL
NF-kB	NULL
DNA	NULL
binding	NULL
subunits	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
1-day	NULL
cultured	NULL
monocytes	NULL
(	NULL
4	NULL
)	NULL
and	NULL
7-day	NULL
cultured	NULL
macrophages	NULL
(	NULL
B	NULL
)	NULL
were	NULL
preincubated	NULL
with	NULL
NF-	NULL
«	NULL
B-specific	NULL
antisera	NULL
(	NULL
1:20	NULL
dilution	NULL
;	NULL
Lanes	NULL
2-9	NULL
)	NULL
for	NULL
30	NULL
min	NULL
and	NULL
then	NULL
allowed	NULL
to	NULL
interact	NULL
with	NULL
a	NULL
P-labeled	NULL
probe	NULL
,	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Antisera	NULL
specific	NULL
for	NULL
NF-kB	NULL
p50	NULL
(	NULL
p50	NULL
)	NULL
,	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
(	NULL
RelA	NULL
)	NULL
,	NULL
c-Rel	NULL
(	NULL
c-re/	NULL
)	NULL
,	NULL
and	NULL
lyt-10	NULL
(	NULL
yt10	NULL
)	NULL
were	NULL
used	NULL
(	NULL
48	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
antibody-protein	NULL
complex	NULL
was	NULL
confirmed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
excess	NULL
peptide	NULL
as	NULL
a	NULL
competitor	NULL
{	NULL
fames	NULL
3	NULL
,	NULL
5	NULL
,	NULL
7	NULL
,	NULL
and	NULL
9	NULL
)	NULL
.	NULL

NF-	NULL
«	NULL
B2	NULL
(	NULL
p100/p52	NULL
)	NULL
,	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
,	NULL
and	NULL
c-Rel	NULL
subunits	NULL
were	NULL
preincubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
labeled	NULL
oligodeoxynucleotide	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
Lane	NULL
2	NULL
,	NULL
preincubation	NULL
with	NULL
the	NULL
NH	NULL
;	NULL
terminal-reactive	NULL
anti-p105/p50	NULL
resulted	NULL
in	NULL
the	NULL
shift	NULL
of	NULL
complex	NULL
A	NULL
.	NULL

The	NULL
appearance	NULL
of	NULL
the	NULL
shifted	NULL
band	NULL
was	NULL
completely	NULL
blocked	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
an	NULL
excess	NULL
amount	NULL
of	NULL
the	NULL
peptide	NULL
used	NULL
for	NULL
antibody	NULL
production	NULL
Day	NULL
1o	NULL
2	NULL
30	NULL
7	NULL
66	NULL
-	NULL
~	NULL
Day	NULL
102	NULL
3	NULL
7	NULL
66	NULL
45	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
p50	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
.	NULL

Cell	NULL
extracts	NULL
(	NULL
15	NULL
ug	NULL
)	NULL
from	NULL
monocytes	NULL
cultured	NULL
for	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
,	NULL
or	NULL
7	NULL
days	NULL
were	NULL
diluted	NULL
1:2	NULL
in	NULL
2x	NULL
SDS	NULL
buffer	NULL
,	NULL
boiled	NULL
10	NULL
min	NULL
,	NULL
loaded	NULL
on	NULL
12.5	NULL
%	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
.	NULL

The	NULL
nitrocellulose	NULL
was	NULL
then	NULL
incubated	NULL
with	NULL
either	NULL
anti-RelA	NULL
(	NULL
p65	NULL
)	NULL
(	NULL
4	NULL
)	NULL
or	NULL
anti-p50	NULL
antibodies	NULL
(	NULL
B	NULL
;	NULL
1:1000	NULL
dilution	NULL
)	NULL
.	NULL

Membranes	NULL
were	NULL
further	NULL
processed	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
Lane	NULL
3	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
no	NULL
shifted	NULL
bands	NULL
were	NULL
obtained	NULL
after	NULL
preincubation	NULL
of	NULL
the	NULL
extracts	NULL
with	NULL
antibodies	NULL
to	NULL
Re-IA	NULL
(	NULL
p65	NULL
)	NULL
,	NULL
c-Rel	NULL
,	NULL
or	NULL
lyt-10	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
Lanes	NULL
4-10	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
by	NULL
using	NULL
WCEs	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
preincubation	NULL
of	NULL
extracts	NULL
from	NULL
7-day	NULL
MDMs	NULL
with	NULL
antibodies	NULL
to	NULL
p50	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
shift	NULL
of	NULL
both	NULL
complexes	NULL
A	NULL
and	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
Lane	NULL
2	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
antibodies	NULL
to	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
were	NULL
capable	NULL
of	NULL
efficiently	NULL
shifting	NULL
complex	NULL
B	NULL
but	NULL
not	NULL
complex	NULL
A	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
Lane	NULL
4	NULL
)	NULL
.	NULL

Antibodies	NULL
to	NULL
c-Rel	NULL
and	NULL
lyt-10	NULL
were	NULL
completely	NULL
ineffective	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
Lanes	NULL
6-9	NULL
)	NULL
.	NULL

The	NULL
appearance	NULL
of	NULL
the	NULL
shifted	NULL
complex	NULL
was	NULL
completely	NULL
inhibited	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
-specific	NULL
peptide	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
Lane	NULL
5	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
formation	NULL
of	NULL
complex	NULL
B	NULL
in	NULL
mature	NULL
macrophages	NULL
is	NULL
due	NULL
to	NULL
the	NULL
appearance	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

Synthesis	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
Protein	NULL
during	NULL
Differentiation	NULL
of	NULL
Monocytes	NULL
to	NULL
Macrophages	NULL
.	NULL

To	NULL
further	NULL
investigate	NULL
whether	NULL
the	NULL
appearance	NULL
of	NULL
complex	NULL
B	NULL
in	NULL
differentiated	NULL
macrophages	NULL
was	NULL
the	NULL
result	NULL
of	NULL
de	NULL
novo	NULL
expression	NULL
of	NULL
Re-IA	NULL
(	NULL
p65	NULL
)	NULL
protein	NULL
,	NULL
Western	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
with	NULL
WCEs	NULL
from	NULL
monocytes	NULL
at	NULL
different	NULL
stages	NULL
of	NULL
differentiation	NULL
.	NULL

Interestingly	NULL
,	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
monocytes	NULL
cultured	NULL
for	NULL
1	NULL
and	NULL
2	NULL
days	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

A	NULL
slight	NULL
expression	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
protein	NULL
was	NULL
observed	NULL
in	NULL
extracts	NULL
from	NULL
3-day	NULL
monocytes	NULL
,	NULL
but	NULL
maximal	NULL
expression	NULL
was	NULL
observed	NULL
in	NULL
7-day	NULL
MDMs	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
five	NULL
separate	NULL
experiments	NULL
performed	NULL
with	NULL
WCEs	NULL
from	NULL
different	NULL
donors	NULL
.	NULL

in	NULL
contrast	NULL
,	NULL
p50	NULL
protein	NULL
was	NULL
constitutively	NULL
synthesized	NULL
in	NULL
1-day	NULL
monocytes	NULL
,	NULL
and	NULL
its	NULL
expression	NULL
did	NULL
not	NULL
vary	NULL
during	NULL
in	NULL
vitro	NULL
culture	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
result	NULL
,	NULL
the	NULL
level	NULL
of	NULL
NF-	NULL
«	NULL
B1	NULL
p105	NULL
did	NULL
not	NULL
vary	NULL
throughout	NULL
monocyte-to-mac-rophage	NULL
differentiation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Synthesis	NULL
of	NULL
IxBa	NULL
Protein	NULL
during	NULL
Differentiation	NULL
of	NULL
Monocytes	NULL
to	NULL
Macrophages	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
the	NULL
induction	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
synthesis	NULL
could	NULL
affect	NULL
the	NULL
expression	NULL
437	NULL
438	NULL
-	NULL
NF-	NULL
«	NULL
B	NULL
Expression	NULL
in	NULL
Differentiating	NULL
Monocytes	NULL
Day	NULL
1	NULL
2	NULL
3	NULL
7	NULL
7	NULL
Peptide	NULL
_-	NULL
-	NULL
-	NULL
-	NULL
+	NULL
29	NULL
-|	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
IxB-	NULL
«	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

3	NULL
and	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
by	NULL
using	NULL
a	NULL
1:1000	NULL
dilution	NULL
of	NULL
an	NULL
antibody	NULL
specific	NULL
for	NULL
the	NULL
NH-terminal	NULL
region	NULL
of	NULL
IxB-a	NULL
protein	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
antibody-protein	NULL
interaction	NULL
was	NULL
confirmed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
excess	NULL
specific	NULL
peptide	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
as	NULL
a	NULL
competitor	NULL
(	NULL
+	NULL
)	NULL
.	NULL

of	NULL
the	NULL
inhibitory	NULL
molecule	NULL
IkBa	NULL
,	NULL
Western	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
by	NULL
using	NULL
an	NULL
antibody	NULL
specific	NULL
to	NULL
the	NULL
IkBa	NULL
NH	NULL
;	NULL
-terminal	NULL
domain	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
two	NULL
different	NULL
bands	NULL
of	NULL
approximately	NULL
M	NULL
,	NULL
37,000	NULL
and	NULL
M	NULL
,	NULL
40,000	NULL
were	NULL
resolved	NULL
by	NULL
this	NULL
antibody	NULL
.	NULL

Interestingly	NULL
,	NULL
both	NULL
bands	NULL
disappeared	NULL
when	NULL
the	NULL
antiserum	NULL
was	NULL
first	NULL
preincubated	NULL
with	NULL
the	NULL
peptide	NULL
against	NULL
which	NULL
it	NULL
was	NULL
raised	NULL
,	NULL
thereby	NULL
demonstrating	NULL
that	NULL
they	NULL
both	NULL
represented	NULL
specific	NULL
IxBa	NULL
species	NULL
.	NULL

Both	NULL
bands	NULL
were	NULL
expressed	NULL
at	NULL
low	NULL
levels	NULL
in	NULL
freshly	NULL
isolated	NULL
monocytes	NULL
.	NULL

A	NULL
time-dependent	NULL
enhancement	NULL
of	NULL
IxBa	NULL
expression	NULL
was	NULL
observed	NULL
during	NULL
monocytic	NULL
differentiation	NULL
,	NULL
and	NULL
notably	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
M	NULL
,	NULL
37,000	NULL
I	NULL
«	NULL
Ba	NULL
form	NULL
occurred	NULL
more	NULL
rapidly	NULL
.	NULL

Stimulation	NULL
of	NULL
cells	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
inducers	NULL
leads	NULL
to	NULL
phosphorylation	NULL
and	NULL
rapid	NULL
loss	NULL
of	NULL
IkBa	NULL
(	NULL
32	NULL
)	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
a	NULL
new	NULL
slowly	NULL
migrating	NULL
form	NULL
of	NULL
IkBa	NULL
has	NULL
been	NULL
observed	NULL
immediately	NULL
after	NULL
treatment	NULL
of	NULL
U937	NULL
cells	NULL
with	NULL
different	NULL
stimuli	NULL
(	NULL
18	NULL
,	NULL
32	NULL
)	NULL
.	NULL

According	NULL
to	NULL
these	NULL
observations	NULL
,	NULL
stimulation	NULL
of	NULL
MDMs	NULL
with	NULL
TNF-a	NULL
and	NULL
LPS	NULL
resulted	NULL
in	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
phosphorylated	NULL
band	NULL
just	NULL
above	NULL
the	NULL
M	NULL
,	NULL
37,000	NULL
form	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
Lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
the	NULL
slowly	NULL
migrating	NULL
IkBa	NULL
form	NULL
observed	NULL
in	NULL
monocytes/macrophages	NULL
could	NULL
be	NULL
a	NULL
hyperphosphorylated	NULL
form	NULL
,	NULL
WCEs	NULL
from	NULL
7-day	NULL
MDMs	NULL
were	NULL
treated	NULL
with	NULL
shrimp	NULL
alkaline	NULL
phosphatase	NULL
prior	NULL
to	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5B	NULL
(	NULL
Lane	NULL
2	NULL
)	NULL
,	NULL
phosphatase	NULL
treatment	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
high	NULL
molecular	NULL
weight	NULL
form	NULL
(	NULL
M	NULL
,	NULL
40,000	NULL
)	NULL
of	NULL
IkBa	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
phosphatase	NULL
treatment	NULL
resulted	NULL
in	NULL
the	NULL
complete	NULL
disappearance	NULL
of	NULL
the	NULL
phosphorylated	NULL
band	NULL
induced	NULL
in	NULL
TNF-	NULL
«	NULL
-	NULL
and	NULL
LPS-treated	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
also	NULL
obtained	NULL
when	NULL
calf	NULL
intestinal	NULL
phosphatase	NULL
was	NULL
used	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
thereby	NULL
indicating	NULL
that	NULL
the	NULL
novel	NULL
M	NULL
,	NULL
40,000	NULL
form	NULL
detected	NULL
in	NULL
monocyte	NULL
extracts	NULL
was	NULL
not	NULL
a	NULL
serine-phosphorylated	NULL
form	NULL
of	NULL
IkBa	NULL
.	NULL

To	NULL
further	NULL
investigate	NULL
whether	NULL
the	NULL
two	NULL
IkBa	NULL
components	NULL
could	NULL
undergo	NULL
degradation	NULL
following	NULL
appropriate	NULL
stimula-tion	NULL
,	NULL
experiments	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
calpain	NULL
inhibitor	NULL
I	NULL
were	NULL
carried	NULL
out	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5C	NULL
,	NULL
Lane	NULL
2	NULL
,	NULL
treatment	NULL
of	NULL
7-day	NULL
MDMs	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
cycloheximide	NULL
and	NULL
TNF-a	NULL
rapidly	NULL
induced	NULL
degradation	NULL
of	NULL
both	NULL
M	NULL
,	NULL
37,000	NULL
and	NULL
M	NULL
,	NULL
40,000	NULL
forms	NULL
.	NULL

Although	NULL
the	NULL
degradation	NULL
of	NULL
the	NULL
M	NULL
,	NULL
37,000	NULL
band	NULL
occurred	NULL
to	NULL
a	NULL
lower	NULL
extent	NULL
compared	NULL
to	NULL
the	NULL
M	NULL
,	NULL
40,000	NULL
form	NULL
,	NULL
the	NULL
degradation	NULL
of	NULL
both	NULL
bands	NULL
was	NULL
markedly	NULL
inhibited	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
protease	NULL
inhibitor	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
,	NULL
Lane	NULL
4	NULL
)	NULL
.	NULL

SAP	NULL
il	NULL
inhibitors	NULL
+	NULL
4	NULL
C	NULL
CALPAIN	NULL
inhib	NULL
.	NULL

-	NULL
-	NULL
++	NULL
CHX	NULL
+	NULL
TNF-	NULL
o.	NULL
eae	NULL
1	NULL
2	NULL
3	NULL
4	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
two	NULL
IxBa	NULL
forms	NULL
.	NULL

A	NULL
,	NULL
induction	NULL
of	NULL
ixBa	NULL
phosphorylation	NULL
.	NULL

7-day	NULL
MDMs	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
LPS	NULL
(	NULL
1	NULL
mg/ml	NULL
;	NULL
Lane	NULL
1	NULL
)	NULL
or	NULL
TNF-	NULL
«	NULL
(	NULL
10	NULL
ng/ml	NULL
;	NULL
Lane	NULL
2	NULL
)	NULL
.	NULL

WCEs	NULL
(	NULL
15	NULL
ug	NULL
)	NULL
were	NULL
subject	NULL
to	NULL
Western	NULL
blot	NULL
analysis	NULL
,	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
by	NULL
using	NULL
a	NULL
1:500	NULL
dilution	NULL
of	NULL
AR20	NULL
antibody	NULL
.	NULL

Arrow	NULL
,	NULL
the	NULL
phosphorylated	NULL
band	NULL
.	NULL

B	NULL
,	NULL
effect	NULL
of	NULL
phosphatase	NULL
treatment	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
M	NULL
,	NULL
40,000	NULL
form	NULL
of	NULL
I	NULL
«	NULL
Ba	NULL
.	NULL

WCEs	NULL
from	NULL
7-day	NULL
MDMs	NULL
were	NULL
incubated	NULL
with	NULL
shrimp	NULL
alkaline	NULL
phosphatase	NULL
(	NULL
SAP	NULL
)	NULL
alone	NULL
(	NULL
Lane	NULL
2	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
phosphatase	NULL
inhibitors	NULL
(	NULL
Lane	NULL
3	NULL
)	NULL
and	NULL
then	NULL
analyzed	NULL
by	NULL
Western	NULL
blot	NULL
.	NULL

C	NULL
,	NULL
effect	NULL
of	NULL
a	NULL
calpain	NULL
inhibitor	NULL
on	NULL
the	NULL
induced	NULL
degradation	NULL
of	NULL
IxBa	NULL
.	NULL

7-day	NULL
MDMs	NULL
were	NULL
preincubated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
calpain	NULL
inhibitor	NULL
I	NULL
(	NULL
100	NULL
um	NULL
;	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
prior	NULL
to	NULL
stimulation	NULL
with	NULL
cycloheximide	NULL
(	NULL
CHX	NULL
;	NULL
50	NULL
ug/ml	NULL
!	NULL
)	NULL

and	NULL
TNF-a	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
30	NULL
min	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
.	NULL

WCEs	NULL
were	NULL
prepared	NULL
and	NULL
processed	NULL
as	NULL
described	NULL
in	NULL
A	NULL
.	NULL

inhib	NULL
.	NULL

,	NULL
inhibitor	NULL
.	NULL

Effect	NULL
of	NULL
Macrophage	NULL
Differentiation	NULL
on	NULL
the	NULL
Expression	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
mRNA	NULL
.	NULL

To	NULL
establish	NULL
whether	NULL
the	NULL
lack	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
synthesis	NULL
in	NULL
1-day	NULL
monocytes	NULL
could	NULL
be	NULL
because	NULL
of	NULL
a	NULL
reduced	NULL
expression	NULL
of	NULL
the	NULL
RelA¥A	NULL
(	NULL
p65	NULL
)	NULL
mRNA	NULL
,	NULL
we	NULL
carried	NULL
out	NULL
RT-PCR	NULL
analysis	NULL
on	NULL
RNA	NULL
samples	NULL
that	NULL
were	NULL
extracted	NULL
from	NULL
monocytes	NULL
cultured	NULL
for	NULL
1	NULL
or	NULL
7	NULL
days	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
mRNA	NULL
accumulated	NULL
at	NULL
comparable	NULL
levels	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
.	NULL

However	NULL
,	NULL
to	NULL
better	NULL
evaluate	NULL
the	NULL
effect	NULL
of	NULL
macrophage	NULL
differentiation	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
mRNA	NULL
,	NULL
we	NULL
also	NULL
measured	NULL
the	NULL
relative	NULL
stability	NULL
of	NULL
this	NULL
mRNA	NULL
.	NULL

Ac-cordingly	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
prepared	NULL
from	NULL
1-day	NULL
monocytes	NULL
and	NULL
7-day	NULL
cultured	NULL
macrophages	NULL
at	NULL
different	NULL
times	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
actinomycin	NULL
D.	NULL
The	NULL
rate	NULL
of	NULL
RelA	NULL
{	NULL
(	NULL
p65	NULL
)	NULL
mRNA	NULL
decay	NULL
was	NULL
then	NULL
determined	NULL
by	NULL
RT-PCR	NULL
during	NULL
the	NULL
following	NULL
6	NULL
h.	NULL
The	NULL
GAPDH	NULL
mRNA	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
because	NULL
its	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
100	NULL
S	NULL
&	NULL
E	NULL
jad	NULL
&	NULL
10	NULL
J	NULL
.	NULL

0	NULL
C	NULL
8	NULL
_	NULL
5	NULL
Q	NULL
«	NULL
-I	NULL
1	NULL
I	NULL
I	NULL
I	NULL
1	NULL
I	NULL
T	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
time	NULL
(	NULL
hours	NULL
)	NULL
day	NULL
1	NULL
day	NULL
7	NULL
0	NULL
2	NULL
460	NULL
0246	NULL
&	NULL
=	NULL
]	NULL
(	NULL
se-GAPDH|—	NULL
{	NULL
_J	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

RT-PCR	NULL
analysis	NULL
of	NULL
the	NULL
RelA	NULL
(	NULL
p6§5	NULL
)	NULL
subunit	NULL
mRNA	NULL
expression	NULL
.	NULL

1-day	NULL
cultured	NULL
monocytes	NULL
(	NULL
@	NULL
)	NULL
and	NULL
7-day	NULL
cultured	NULL
macrophages	NULL
(	NULL
O	NULL
;	NULL
3	NULL
x	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
treated	NULL
with	NULL
10	NULL
ug/ml	NULL
!	NULL

of	NULL
actinomycin	NULL
D.	NULL
Total	NULL
RNA	NULL
was	NULL
extracted	NULL
after	NULL
2	NULL
,	NULL
4	NULL
,	NULL
and	NULL
6	NULL
h	NULL
,	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

RNA	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
was	NULL
retrotranscribed	NULL
and	NULL
amplified	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Autoradiographs	NULL
were	NULL
scanned	NULL
for	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
and	NULL
GAPDH	NULL
cDNA	NULL
.	NULL

The	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
values	NULL
were	NULL
normalized	NULL
against	NULL
the	NULL
GAPDH	NULL
values	NULL
.	NULL

RelA	NULL
(	NULL
p65	NULL
)	NULL
values	NULL
were	NULL
expressed	NULL
as	NULL
percentages	NULL
,	NULL
with	NULL
the	NULL
100	NULL
%	NULL
value	NULL
assigned	NULL
to	NULL
the	NULL
level	NULL
present	NULL
at	NULL
time	NULL
0	NULL
,	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
actinomycin	NULL
D.	NULL
The	NULL
values	NULL
given	NULL
(	NULL
fop	NULL
pane	NULL
!	NULL
)	NULL

are	NULL
the	NULL
mean	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

Bottom	NULL
panel	NULL
,	NULL
the	NULL
results	NULL
of	NULL
one	NULL
representative	NULL
experiment	NULL
.	NULL

Rel	NULL
A	NULL
stability	NULL
was	NULL
not	NULL
modified	NULL
by	NULL
actinomycin	NULL
D	NULL
during	NULL
the	NULL
time	NULL
of	NULL
treatment	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
the	NULL
half-life	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
mRNA	NULL
was	NULL
observed	NULL
in	NULL
7-day	NULL
MDMs	NULL
(	NULL
t/	NULL
~	NULL
2.5	NULL
h	NULL
)	NULL
as	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
1-day	NULL
monocytes	NULL
(	NULL
1	NULL
%	NULL
~	NULL
30	NULL
min	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
stability	NULL
of	NULL
the	NULL
p50	NULL
and	NULL
IkBa	NULL
mRNAs	NULL
was	NULL
unchanged	NULL
during	NULL
macrophage	NULL
differentiation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
lack	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
protein	NULL
expression	NULL
in	NULL
1-day	NULL
monocytes	NULL
may	NULL
be	NULL
because	NULL
of	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
the	NULL
more	NULL
rapid	NULL
turnover	NULL
of	NULL
its	NULL
mRNA	NULL
,	NULL
whereas	NULL
the	NULL
accumulation	NULL
of	NULL
the	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
protein	NULL
in	NULL
7-day	NULL
MDMs	NULL
may	NULL
reflect	NULL
a	NULL
reduced	NULL
degradation	NULL
rate	NULL
of	NULL
the	NULL
corresponding	NULL
mRNA	NULL
.	NULL

Discussion	NULL
Previous	NULL
studies	NULL
performed	NULL
using	NULL
monocytic	NULL
tumor	NULL
cell	NULL
lines	NULL
have	NULL
demonstrated	NULL
that	NULL
macrophage	NULL
differentiation	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
modulation	NULL
in	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
(	NULL
21	NULL
,	NULL
25-28	NULL
)	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
Griffin	NULL
et	NULL
a/	NULL
.	NULL

(	NULL
21	NULL
)	NULL
showed	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
appeared	NULL
during	NULL
the	NULL
transition	NULL
from	NULL
promonocyte	NULL
to	NULL
monocyte	NULL
in	NULL
U937	NULL
cells	NULL
induced	NULL
to	NULL
differentiate	NULL
in	NULL
vitro	NULL
by	NULL
PMA	NULL
and	NULL
that	NULL
NF-	NULL
«	NULL
B-dependent	NULL
transcription	NULL
was	NULL
specifically	NULL
enhanced	NULL
.	NULL

The	NULL
pattern	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
«	NULL
B	NULL
binding	NULL
proteins	NULL
has	NULL
been	NULL
subsequently	NULL
explored	NULL
in	NULL
more	NULL
detail	NULL
by	NULL
Kaufman	NULL
et	NULL
a/	NULL
.	NULL

(	NULL
27	NULL
)	NULL
in	NULL
human	NULL
monocytic	NULL
cell	NULL
lines	NULL
.	NULL

These	NULL
authors	NULL
found	NULL
a	NULL
constitutive	NULL
expression	NULL
of	NULL
p50	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
both	NULL
unstimulated	NULL
U937	NULL
and	NULL
THP-1	NULL
cells	NULL
,	NULL
whereas	NULL
a	NULL
constitutive	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
expression	NULL
was	NULL
only	NULL
found	NULL
in	NULL
THP-1	NULL
cells	NULL
.	NULL

Treatment	NULL
of	NULL
both	NULL
cell	NULL
lines	NULL
with	NULL
TNF-a	NULL
lead	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
p50	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
proteins	NULL
.	NULL

These	NULL
authors	NULL
concluded	NULL
that	NULL
the	NULL
different	NULL
pattern	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
subunits	NULL
expression	NULL
in	NULL
these	NULL
monocytic	NULL
cells	NULL
was	NULL
dependent	NULL
on	NULL
cellular	NULL
differentiation	NULL
(	NULL
27	NULL
)	NULL
.	NULL

The	NULL
relationships	NULL
among	NULL
HIV	NULL
infection	NULL
of	NULL
myeloid	NULL
cells	NULL
,	NULL
induction	NULL
of	NULL
NF-kB	NULL
binding	NULL
activity	NULL
,	NULL
cellular	NULL
differentiation	NULL
,	NULL
and	NULL
HIV-1	NULL
gene	NULL
expression	NULL
have	NULL
also	NULL
been	NULL
examined	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
Roulston	NULL
et	NULL
a/	NULL
.	NULL

(	NULL
26	NULL
,	NULL
28	NULL
)	NULL
reported	NULL
that	NULL
a	NULL
dramatic	NULL
alteration	NULL
in	NULL
protein-DNA	NULL
interactions	NULL
occurring	NULL
at	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
recognition	NULL
site	NULL
took	NULL
place	NULL
during	NULL
myeloid	NULL
differentiation	NULL
,	NULL
concomitant	NULL
with	NULL
HIV-1	NULL
infection	NULL
.	NULL

However	NULL
,	NULL
a	NULL
detailed	NULL
characterization	NULL
of	NULL
NF-kB	NULL
subunits	NULL
during	NULL
the	NULL
differentiation	NULL
of	NULL
primary	NULL
monocytes	NULL
to	NULL
macrophages	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
reported	NULL
.	NULL

Peripheral	NULL
blood	NULL
monocytes	NULL
mature	NULL
in	NULL
different	NULL
types	NULL
of	NULL
tissue	NULL
histiocytes	NULL
when	NULL
they	NULL
migrate	NULL
from	NULL
the	NULL
bloodstream	NULL
to	NULL
various	NULL
tissues	NULL
.	NULL

This	NULL
differentiation	NULL
is	NULL
essential	NULL
for	NULL
their	NULL
functional	NULL
competence	NULL
and	NULL
is	NULL
probably	NULL
triggered	NULL
by	NULL
environmental	NULL
signals	NULL
.	NULL

/n	NULL
vitro	NULL
cultivation	NULL
of	NULL
blood	NULL
monocytes	NULL
results	NULL
in	NULL
their	NULL
adherence	NULL
to	NULL
the	NULL
plastic	NULL
surface	NULL
and	NULL
in	NULL
the	NULL
initiation	NULL
of	NULL
a	NULL
series	NULL
of	NULL
characteristic	NULL
changes	NULL
that	NULL
closely	NULL
resemble	NULL
those	NULL
occurring	NULL
during	NULL
their	NULL
in	NULL
vivo	NULL
maturation	NULL
to	NULL
macrophages	NULL
(	NULL
29-31	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
in	NULL
vitro	NULL
cultured	NULL
MDMs	NULL
represent	NULL
a	NULL
unique	NULL
cell	NULL
model	NULL
to	NULL
investigate	NULL
the	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
factors	NULL
during	NULL
macrophage	NULL
differentiation	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
described	NULL
qualitative	NULL
changes	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
NF-kB	NULL
subunits	NULL
during	NULL
the	NULL
differentiation	NULL
of	NULL
human	NULL
monocytes	NULL
to	NULL
macrophages	NULL
.	NULL

Although	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
was	NULL
detected	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
both	NULL
1-day	NULL
cultured	NULL
monocytes	NULL
and	NULL
7-day	NULL
MDMs	NULL
,	NULL
an	NULL
additional	NULL
complex	NULL
appeared	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
7-day	NULL
MDMs	NULL
.	NULL

This	NULL
complex	NULL
,	NULL
designated	NULL
complex	NULL
B	NULL
,	NULL
was	NULL
characterized	NULL
by	NULL
a	NULL
slower	NULL
electrophoretic	NULL
mobility	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
constitutively	NULL
expressed	NULL
complex	NULL
A	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Super-shift	NULL
assays	NULL
performed	NULL
with	NULL
antibodies	NULL
specific	NULL
for	NULL
the	NULL
p50	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
proteins	NULL
showed	NULL
that	NULL
complex	NULL
A	NULL
was	NULL
composed	NULL
of	NULL
p50/p50	NULL
homodimers	NULL
,	NULL
whereas	NULL
heterodimers	NULL
pS50/	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
participated	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
complex	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
agree	NULL
with	NULL
those	NULL
of	NULL
other	NULL
authors	NULL
(	NULL
21-24	NULL
)	NULL
,	NULL
who	NULL
also	NULL
detected	NULL
a	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
in	NULL
unstimulated	NULL
primary	NULL
monocytes	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Suzan	NULL
et	NULL
al	NULL
.	NULL

(	NULL
25	NULL
)	NULL
failed	NULL
to	NULL
detect	NULL
such	NULL
binding	NULL
activity	NULL
in	NULL
primary	NULL
monocytes	NULL
.	NULL

This	NULL
discrepancy	NULL
may	NULL
be	NULL
due	NULL
to	NULL
differences	NULL
in	NULL
the	NULL
method	NULL
used	NULL
to	NULL
prepare	NULL
the	NULL
monocytes/macrophages	NULL
and/or	NULL
in	NULL
the	NULL
source	NULL
of	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
.	NULL

Western	NULL
blot	NULL
440	NULL
-	NULL
NF-	NULL
«	NULL
B	NULL
Expression	NULL
in	NULL
Differentiating	NULL
Monocytes	NULL
ting	NULL
analysis	NULL
showed	NULL
that	NULL
the	NULL
absence	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
activity	NULL
in	NULL
1-day	NULL
monocytes	NULL
could	NULL
be	NULL
explained	NULL
by	NULL
a	NULL
lack	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
protein	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
RelA¥A	NULL
(	NULL
p65	NULL
)	NULL
expression	NULL
was	NULL
demonstrated	NULL
only	NULL
in	NULL
cell	NULL
extracts	NULL
derived	NULL
from	NULL
MDMs	NULL
cultured	NULL
in	NULL
vitro	NULL
for	NULL
at	NULL
least	NULL
3	NULL
days	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
with	NULL
our	NULL
results	NULL
,	NULL
Lofquist	NULL
et	NULL
al	NULL
.	NULL

(	NULL
23	NULL
)	NULL
reported	NULL
the	NULL
presence	NULL
of	NULL
low	NULL
levels	NULL
of	NULL
p5O/ReIA	NULL
(	NULL
p6S5	NULL
)	NULL
complexes	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
unstimulated	NULL
monocytes	NULL
.	NULL

A	NULL
difference	NULL
in	NULL
the	NULL
monocyte	NULL
isolation	NULL
procedure	NULL
,	NULL
the	NULL
possible	NULL
presence	NULL
of	NULL
contaminant	NULL
LPS	NULL
,	NULL
and	NULL
the	NULL
timing	NULL
of	NULL
cell	NULL
processing	NULL
after	NULL
isolation	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
may	NULL
account	NULL
for	NULL
this	NULL
discrepancy	NULL
.	NULL

Franzoso	NULL
et	NULL
al	NULL
.	NULL

(	NULL
33	NULL
)	NULL
reported	NULL
recently	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
novel	NULL
,	NULL
faster-migrating	NULL
NF-	NULL
«	NULL
B	NULL
complex	NULL
,	NULL
characterized	NULL
by	NULL
a	NULL
specific	NULL
truncation	NULL
of	NULL
the	NULL
COOH-terminal	NULL
of	NULL
the	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
subunit	NULL
.	NULL

This	NULL
specific	NULL
truncation	NULL
removes	NULL
the	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
transactivation	NULL
function	NULL
but	NULL
not	NULL
the	NULL
DNA	NULL
binding	NULL
or	NULL
dimer-ization	NULL
functions	NULL
.	NULL

The	NULL
appearance	NULL
of	NULL
this	NULL
novel	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
form	NULL
was	NULL
correlated	NULL
with	NULL
the	NULL
activity	NULL
of	NULL
specific	NULL
serine	NULL
pro-teases	NULL
,	NULL
termed	NULL
serprocidins	NULL
,	NULL
that	NULL
are	NULL
dramatically	NULL
down-regulated	NULL
by	NULL
macrophage	NULL
differentiating	NULL
agents	NULL
.	NULL

Using	NULL
an	NULL
antibody	NULL
specific	NULL
to	NULL
the	NULL
domain	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
and	NULL
the	NULL
protease	NULL
inhibitors	NULL
used	NULL
by	NULL
Franzoso	NULL
et	NULL
al	NULL
.	NULL

(	NULL
33	NULL
)	NULL
,	NULL
we	NULL
failed	NULL
to	NULL
detect	NULL
this	NULL
truncated	NULL
form	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
in	NULL
both	NULL
monocytes	NULL
and	NULL
7-day	NULL
cultured	NULL
macrophages	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
finding	NULL
that	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
can	NULL
be	NULL
induced	NULL
in	NULL
1-day	NULL
monocytes	NULL
after	NULL
a	NULL
30-min	NULL
treatment	NULL
with	NULL
PMA	NULL
further	NULL
indicates	NULL
that	NULL
the	NULL
lack	NULL
of	NULL
expression	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
in	NULL
freshly	NULL
harvested	NULL
cells	NULL
is	NULL
not	NULL
due	NULL
to	NULL
protein	NULL
degradation	NULL
during	NULL
the	NULL
extraction	NULL
procedures	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
expression	NULL
is	NULL
correlated	NULL
in	NULL
part	NULL
with	NULL
increased	NULL
stabilization	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
p50	NULL
subunit	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
and	NULL
its	NULL
precursor	NULL
p105	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
were	NULL
expressed	NULL
constitutively	NULL
in	NULL
freshly	NULL
isolated	NULL
monocytes	NULL
,	NULL
and	NULL
their	NULL
level	NULL
did	NULL
not	NULL
change	NULL
during	NULL
the	NULL
differentiation	NULL
from	NULL
monocytes	NULL
to	NULL
macrophages	NULL
.	NULL

A	NULL
direct	NULL
correlation	NULL
was	NULL
found	NULL
between	NULL
the	NULL
expression	NULL
of	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
subunit	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
and	NULL
IkBa	NULL
synthesis	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
in	NULL
MDMs	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
it	NULL
was	NULL
reported	NULL
recently	NULL
that	NULL
the	NULL
transcription	NULL
of	NULL
IxBa	NULL
mRNA	NULL
was	NULL
rapidly	NULL
induced	NULL
by	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
complexes	NULL
on	NULL
treatment	NULL
with	NULL
PMA	NULL
or	NULL
LPS	NULL
(	NULL
15-18	NULL
)	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
I	NULL
«	NULL
Ba	NULL
is	NULL
directly	NULL
mediated	NULL
by	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
present	NULL
in	NULL
the	NULL
upstream	NULL
promoter	NULL
element	NULL
of	NULL
the	NULL
/xBa	NULL
gene	NULL
(	NULL
15-18	NULL
)	NULL
.	NULL

IxBa	NULL
is	NULL
further	NULL
regulated	NULL
posttranscriptionally	NULL
,	NULL
because	NULL
the	NULL
stability	NULL
of	NULL
the	NULL
IxBa	NULL
protein	NULL
is	NULL
greatly	NULL
reduced	NULL
on	NULL
activation	NULL
of	NULL
NF-kB	NULL
activity	NULL
.	NULL

The	NULL
IkBa	NULL
protein	NULL
is	NULL
rapidly	NULL
phosphorylated	NULL
and	NULL
degraded	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
in	NULL
many	NULL
cell	NULL
lines	NULL
(	NULL
7	NULL
,	NULL
11	NULL
,	NULL
13	NULL
,	NULL
14	NULL
,	NULL
34-38	NULL
)	NULL
.	NULL

The	NULL
removal	NULL
of	NULL
I	NULL
«	NULL
kB	NULL
is	NULL
coupled	NULL
to	NULL
a	NULL
concomitant	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
from	NULL
the	NULL
cytoplasm	NULL
into	NULL
the	NULL
nucleus	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
recent	NULL
studies	NULL
(	NULL
18	NULL
,	NULL
32	NULL
)	NULL
reported	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
new	NULL
transient	NULL
species	NULL
of	NULL
IkBa	NULL
in	NULL
U937	NULL
cells	NULL
(	NULL
soon	NULL
after	NULL
stimulation	NULL
with	NULL
TNF-a	NULL
)	NULL
,	NULL
which	NULL
represented	NULL
a	NULL
phosphorylated	NULL
IxkBa	NULL
form	NULL
.	NULL

We	NULL
report	NULL
here	NULL
the	NULL
presence	NULL
of	NULL
two	NULL
different	NULL
IkBa	NULL
species	NULL
in	NULL
extracts	NULL
of	NULL
monocytes/macrophages	NULL
that	NULL
increased	NULL
during	NULL
differentiation	NULL
.	NULL

However	NULL
,	NULL
treatment	NULL
of	NULL
these	NULL
extracts	NULL
with	NULL
two	NULL
different	NULL
phosphatases	NULL
failed	NULL
to	NULL
remove	NULL
the	NULL
upper	NULL
band	NULL
,	NULL
indicating	NULL
that	NULL
this	NULL
IxBa	NULL
component	NULL
was	NULL
not	NULL
a	NULL
serine-phosphorylated	NULL
form	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
an	NULL
alternative	NULL
mechanism	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
involving	NULL
tyrosine	NULL
phospho-	NULL
rylation	NULL
of	NULL
IkBa	NULL
has	NULL
been	NULL
reported	NULL
recently	NULL
(	NULL
39	NULL
)	NULL
.	NULL

in	NULL
light	NULL
of	NULL
this	NULL
observation	NULL
,	NULL
additional	NULL
studies	NULL
are	NULL
required	NULL
to	NULL
establish	NULL
whether	NULL
the	NULL
M	NULL
,	NULL
40,000	NULL
band	NULL
could	NULL
be	NULL
a	NULL
tyrosine-phospho-rylated	NULL
form	NULL
of	NULL
IkBa	NULL
.	NULL

The	NULL
pattern	NULL
of	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
the	NULL
M	NULL
,	NULL
37,000	NULL
form	NULL
in	NULL
response	NULL
to	NULL
different	NULL
stimuli	NULL
occurred	NULL
as	NULL
described	NULL
in	NULL
other	NULL
cell	NULL
models	NULL
,	NULL
although	NULL
with	NULL
delayed	NULL
kinet-ics	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
stabilization	NULL
of	NULL
the	NULL
two	NULL
forms	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
calpain	NULL
inhibitor	NULL
|	NULL
further	NULL
indicates	NULL
that	NULL
both	NULL
forms	NULL
are	NULL
regulated	NULL
by	NULL
phosphorylation	NULL
in	NULL
response	NULL
to	NULL
specific	NULL
stimuli	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
another	NULL
member	NULL
of	NULL
the	NULL
I	NULL
«	NULL
B	NULL
family	NULL
,	NULL
IkBB	NULL
,	NULL
was	NULL
also	NULL
found	NULL
to	NULL
be	NULL
up-regulated	NULL
during	NULL
monocyte	NULL
differentiation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Sequence	NULL
analysis	NULL
identified	NULL
the	NULL
NF-kB	NULL
sequence	NULL
in	NULL
a	NULL
large	NULL
number	NULL
of	NULL
gene-regulatory	NULL
elements	NULL
,	NULL
including	NULL
those	NULL
involved	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
several	NULL
cytokines	NULL
and	NULL
adhesion	NULL
molecules	NULL
.	NULL

Some	NULL
of	NULL
these	NULL
genes	NULL
are	NULL
known	NULL
to	NULL
be	NULL
specifically	NULL
regulated	NULL
during	NULL
cell	NULL
differentiation	NULL
(	NULL
30	NULL
,	NULL
31	NULL
,	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

Notably	NULL
,	NULL
NF-KB	NULL
is	NULL
also	NULL
a	NULL
strong	NULL
transactivator	NULL
of	NULL
HIV~1	NULL
transcription	NULL
,	NULL
particularly	NULL
in	NULL
mononuclear	NULL
phagocytic	NULL
cells	NULL
(	NULL
21	NULL
,	NULL
42	NULL
,	NULL
43	NULL
)	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
monocytes	NULL
and	NULL
macrophages	NULL
differ	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
support	NULL
HIV	NULL
replication	NULL
and	NULL
to	NULL
produce	NULL
some	NULL
cytokines	NULL
(	NULL
TNF-a	NULL
and	NULL
IL-6	NULL
)	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
can	NULL
potentiate	NULL
HIV-1	NULL
replication	NULL
(	NULL
31	NULL
,	NULL
44	NULL
,	NULL
45	NULL
)	NULL
.	NULL

We	NULL
suggest	NULL
that	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
strong	NULL
trans-activating	NULL
subunit	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
in	NULL
the	NULL
nucleus	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
virus	NULL
expression	NULL
in	NULL
HIV-in-fected	NULL
macrophages	NULL
and	NULL
may	NULL
have	NULL
biological	NULL
relevance	NULL
for	NULL
the	NULL
acquisition	NULL
of	NULL
a	NULL
fully	NULL
differentiated	NULL
macrophage	NULL
phenotype	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Isolation	NULL
and	NULL
Culture	NULL
of	NULL
Monocytes	NULL
.	NULL

Peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
were	NULL
obtained	NULL
from	NULL
18-40-year-old	NULL
healthy	NULL
donors	NULL
and	NULL
separated	NULL
by	NULL
using	NULL
Ficoll-Paque	NULL
solution	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
,	NULL
Inc.	NULL
,	NULL
Uppsala	NULL
,	NULL
Swe-den	NULL
)	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Monocytes	NULL
were	NULL
separated	NULL
from	NULL
lym-phocytes	NULL
by	NULL
adherence	NULL
(	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
)	NULL
to	NULL
plastic	NULL
dishes	NULL
.	NULL

After	NULL
removal	NULL
of	NULL
nonadherent	NULL
cells	NULL
,	NULL
monocytes	NULL
were	NULL
extensively	NULL
washed	NULL
and	NULL
cultured	NULL
in	NULL
Iscove	NULL
's	NULL
medium	NULL
containing	NULL
15	NULL
%	NULL
FCS	NULL
(	NULL
0.22	NULL
wm	NULL
filtered	NULL
)	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
;	NULL
in	NULL
air	NULL
at	NULL
37°C	NULL
.	NULL

At	NULL
various	NULL
culture	NULL
times	NULL
(	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
7	NULL
days	NULL
)	NULL
,	NULL
both	NULL
adherent	NULL
and	NULL
nonadherent	NULL
cells	NULL
were	NULL
recovered	NULL
and	NULL
analyzed	NULL
.	NULL

We	NULL
refer	NULL
to	NULL
1-day	NULL
monocytes	NULL
as	NULL
those	NULL
cells	NULL
that	NULL
have	NULL
been	NULL
processed	NULL
24	NULL
h	NULL
after	NULL
cell	NULL
seeding	NULL
when	NULL
adherence-activated	NULL
phenomena	NULL
have	NULL
reverted	NULL
completely	NULL
to	NULL
basal	NULL
levels	NULL
.	NULL

Cytochemical	NULL
(	NULL
sodium	NULL
fluoride-inhibited	NULL
esterase	NULL
activity	NULL
)	NULL
and	NULL
surface	NULL
marker	NULL
(	NULL
CD14	NULL
antigen	NULL
)	NULL
analysis	NULL
revealed	NULL
that	NULL
the	NULL
adherent	NULL
cell	NULL
population	NULL
consisted	NULL
of	NULL
95	NULL
%	NULL
monocytes	NULL
.	NULL

All	NULL
of	NULL
the	NULL
reagents	NULL
used	NULL
for	NULL
monocyte	NULL
isolation	NULL
and	NULL
culture	NULL
were	NULL
endotoxin	NULL
free	NULL
,	NULL
as	NULL
evaluated	NULL
by	NULL
the	NULL
Lymulus	NULL
amebocyte	NULL
lysate	NULL
assay	NULL
.	NULL

Radiobinding	NULL
Assay	NULL
.	NULL

Five	NULL
x	NULL
10°	NULL
monocytes	NULL
were	NULL
incubated	NULL
with	NULL
monoclonal	NULL
antibodies	NULL
against	NULL
TfR	NULL
(	NULL
OKT9	NULL
;	NULL
Ortho	NULL
Diagnostic	NULL
Systems	NULL
,	NULL
Inc.	NULL
)	NULL
,	NULL
CD14	NULL
(	NULL
LeuM3	NULL
;	NULL
Becton	NULL
Dickinson	NULL
)	NULL
,	NULL
or	NULL
CD11b	NULL
(	NULL
OKM1	NULL
;	NULL
Ortho	NULL
Diagnostic	NULL
Systems	NULL
,	NULL
Inc.	NULL
)	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
31	NULL
)	NULL
.	NULL

This	NULL
assay	NULL
was	NULL
performed	NULL
routinely	NULL
to	NULL
check	NULL
the	NULL
extent	NULL
of	NULL
macrophage	NULL
differentiation	NULL
in	NULL
all	NULL
of	NULL
the	NULL
experiments	NULL
.	NULL

Nuclear	NULL
and	NULL
WCE	NULL
Preparation	NULL
.	NULL

Nuclear	NULL
protein	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
46	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
monocytes	NULL
were	NULL
detached	NULL
from	NULL
the	NULL
tissue	NULL
culture	NULL
dish	NULL
by	NULL
using	NULL
a	NULL
rubber	NULL
scraper	NULL
in	NULL
cold	NULL
PBS	NULL
and	NULL
washed	NULL
twice	NULL
before	NULL
being	NULL
resuspended	NULL
in	NULL
lysis	NULL
buffer	NULL
A	NULL
(	NULL
46	NULL
)	NULL
.	NULL

After	NULL
cen-trifugation	NULL
,	NULL
the	NULL
nuclear	NULL
peliet	NULL
was	NULL
suspended	NULL
in	NULL
buffer	NULL
C	NULL
(	NULL
46	NULL
)	NULL
,	NULL
incubated	NULL
15	NULL
min	NULL
on	NULL
ice	NULL
,	NULL
and	NULL
microcentrifuged	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
then	NULL
diluted	NULL
1:5	NULL
with	NULL
buffer	NULL
D	NULL
(	NULL
46	NULL
)	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
.	NULL

WCEs	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
47	NULL
)	NULL
with	NULL
the	NULL
exception	NULL
that	NULL
pepstatin	NULL
,	NULL
aprotinin	NULL
,	NULL
and	NULL
leupeptin	NULL
were	NULL
used	NULL
at	NULL
the	NULL
concentration	NULL
of	NULL
10	NULL
ug/ml	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
6	NULL
ug	NULL
)	NULL
or	NULL
WCEs	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
were	NULL
preincubated	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
nonspecific	NULL
DNA	NULL
competitor	NULL
poly	NULL
(	NULL
deoxyinosinic-deoxycytidylic	NULL
)	NULL
acid	NULL
(	NULL
Pharmacia	NULL
)	NULL
for	NULL
10	NULL
min	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
20	NULL
pl	NULL
of	NULL
a	NULL
reaction	NULL
mixture	NULL
containing	NULL
20	NULL
mm	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
70	NULL
mm	NULL
KCI	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mm	NULL
EDTA	NULL
,	NULL
and	NULL
1	NULL
mm	NULL
DTT	NULL
.	NULL

Binding	NULL
activity	NULL
was	NULL
assessed	NULL
by	NULL
incubating	NULL
the	NULL
extract	NULL
with	NULL
0.2	NULL
ng	NULL
of	NULL
°°P	NULL
end-labeled	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
enhancer	NULL
region	NULL
of	NULL
the	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
5'-AGGGACTTTCCGCTGGGACTTTCC-3	NULL
'	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Protein-DNA	NULL
complexes	NULL
were	NULL
then	NULL
separated	NULL
on	NULL
a	NULL
5	NULL
%	NULL
native	NULL
polyacrylamide	NULL
gel	NULL
(	NULL
60:1	NULL
cross-link	NULL
)	NULL
in	NULL
Tris-glycine	NULL
[	NULL
25	NULL
mm	NULL
Tris	NULL
,	NULL
195	NULL
mm	NULL
glycine	NULL
(	NULL
pH	NULL
8.5	NULL
)	NULL
]	NULL
.	NULL

In	NULL
competition	NULL
analysis	NULL
,	NULL
a	NULL
200	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
oligonucleotide	NULL
or	NULL
of	NULL
a	NULL
mutant	NULL
5'-ACATGGTTTC-CGCTCATGGTTTCC-3	NULL
!	NULL

was	NULL
incubated	NULL
with	NULL
the	NULL
extract	NULL
for	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
probe	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
individual	NULL
proteins	NULL
present	NULL
in	NULL
the	NULL
complexes	NULL
,	NULL
polyclonal	NULL
subunit	NULL
rabbit	NULL
antisera	NULL
(	NULL
48	NULL
)	NULL
,	NULL
specific	NULL
for	NULL
p50/p105	NULL
(	NULL
AR27	NULL
,	NULL
NH	NULL
,	NULL
-terminal	NULL
specific	NULL
)	NULL
,	NULL
RelA	NULL
{	NULL
p65	NULL
)	NULL
(	NULL
AR28	NULL
,	NULL
COOH-terminal	NULL
specific	NULL
)	NULL
,	NULL
c-Rel	NULL
(	NULL
AR22	NULL
,	NULL
COOH-terminal	NULL
specific	NULL
)	NULL
,	NULL
and	NULL
p52/p100	NULL
(	NULL
AR43	NULL
,	NULL
NH	NULL
;	NULL
-terminal	NULL
specific	NULL
)	NULL
were	NULL
incubated	NULL
(	NULL
1:20	NULL
)	NULL
with	NULL
the	NULL
nuclear	NULL
extract	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
specific	NULL
competitor	NULL
peptide	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
before	NULL
the	NULL
binding	NULL
reaction	NULL
.	NULL

Western	NULL
Blot	NULL
Analysis	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
Subunits	NULL
.	NULL

WCEs	NULL
(	NULL
15	NULL
ug	NULL
)	NULL
were	NULL
resolved	NULL
by	NULL
SDS/PAGE	NULL
,	NULL
electrophoretically	NULL
transferred	NULL
to	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
(	NULL
Schleicher	NULL
and	NULL
Schuell	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
rabbit	NULL
antisera	NULL
specific	NULL
for	NULL
p50/p105	NULL
,	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
,	NULL
or	NULL
for	NULL
IxBa	NULL
(	NULL
AR20	NULL
,	NULL
NH	NULL
,	NULL
-terminal	NULL
specific	NULL
)	NULL
at	NULL
a	NULL
dilution	NULL
of	NULL
1:1000	NULL
in	NULL
5	NULL
%	NULL
mill/PBS	NULL
overnight	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
four	NULL
washes	NULL
with	NULL
PBS	NULL
for	NULL
10	NULL
min	NULL
,	NULL
membranes	NULL
were	NULL
reacted	NULL
with	NULL
peroxidase-conjugated	NULL
anti-rabbit	NULL
immunoglobulin	NULL
serum	NULL
(	NULL
Amersham	NULL
Corp.	NULL
)	NULL
and	NULL
visualized	NULL
with	NULL
the	NULL
enhanced	NULL
chemiluminescence	NULL
detection	NULL
system	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

For	NULL
phosphatase	NULL
treatment	NULL
experiments	NULL
,	NULL
WCEs	NULL
from	NULL
7-day	NULL
MDMs	NULL
(	NULL
15	NULL
pg	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
shrimp	NULL
alkaline	NULL
phosphatase	NULL
(	NULL
4	NULL
units	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
phosphatase	NULL
inhibitors	NULL
10	NULL
mm	NULL
and	NULL
NaF	NULL
50	NULL
mm	NULL
)	NULL
and	NULL
then	NULL
were	NULL
subject	NULL
to	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

For	NULL
calpain	NULL
inhibitor	NULL
experiments	NULL
,	NULL
7-day	NULL
MDMs	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
with	NULL
100	NULL
um	NULL
calpain	NULL
inhibitor	NULL
I	NULL
(	NULL
Calbiochem	NULL
)	NULL
and	NULL
then	NULL
treated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
cycloheximide	NULL
(	NULL
50	NULL
ug/mi	NULL
)	NULL
and	NULL
TNF-a	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
.	NULL

RT-PCR	NULL
Analysis	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
Subunit	NULL
mRNA	NULL
.	NULL

Total	NULL
cellular	NULL
RNA	NULL
prepared	NULL
was	NULL
reverse	NULL
transcribed	NULL
and	NULL
subsequently	NULL
amplified	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
49	NULL
)	NULL
.	NULL

The	NULL
cycler	NULL
program	NULL
consisted	NULL
of	NULL
an	NULL
initial	NULL
denaturation	NULL
of	NULL
3	NULL
min	NULL
at	NULL
95°C	NULL
,	NULL
followed	NULL
by	NULL
22	NULL
cycles	NULL
of	NULL
denaturation	NULL
for	NULL
1	NULL
min	NULL
at	NULL
94°C	NULL
,	NULL
primer	NULL
annealing	NULL
for	NULL
2	NULL
min	NULL
at	NULL
58°C	NULL
,	NULL
and	NULL
extension	NULL
for	NULL
3	NULL
min	NULL
at	NULL
72°C	NULL
.	NULL

A	NULL
negative	NULL
control-lacking	NULL
template	NULL
RNA	NULL
or	NULL
RT	NULL
was	NULL
included	NULL
in	NULL
each	NULL
experiment	NULL
.	NULL

The	NULL
PCR	NULL
products	NULL
were	NULL
run	NULL
on	NULL
an	NULL
agarose	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
a	NULL
nylon	NULL
membrane	NULL
,	NULL
and	NULL
hybridized	NULL
to	NULL
specific	NULL
labeled	NULL
DNA	NULL
probes	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
49	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
for	NULL
the	NULL
GAPDH	NULL
and	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
primers	NULL
have	NULL
been	NULL
described	NULL
(	NULL
49	NULL
,	NULL
50	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
probes	NULL
recognize	NULL
sequences	NULL
internal	NULL
to	NULL
the	NULL
amplification	NULL
products	NULL
.	NULL

Their	NULL
sequences	NULL
are	NULL
:	NULL
GAPDH	NULL
,	NULL
CTAAGCATGTGGTGGTGCA	NULL
;	NULL
and	NULL
RelA	NULL
(	NULL
p6§5	NULL
)	NULL
,	NULL
GCATGCGCTTC-CGCTACAAGTGCG	NULL
.	NULL

The	NULL
low	NULL
number	NULL
of	NULL
PCR	NULL
cycles	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
Southern	NULL
blot	NULL
of	NULL
the	NULL
PCR	NULL
products	NULL
,	NULL
ensures	NULL
a	NULL
measurement	NULL
of	NULL
mRNA	NULL
concentrations	NULL
within	NULL
a	NULL
linear	NULL
range	NULL
.	NULL

Analysis	NULL
of	NULL
mRNA	NULL
Half-Life	NULL
,	NULL
Monocytes	NULL
cultured	NULL
for	NULL
1	NULL
or	NULL
7	NULL
days	NULL
were	NULL
treated	NULL
with	NULL
10	NULL
g/m	NULL
!	NULL

of	NULL
actinomycin	NULL
D	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
extracted	NULL
after	NULL
1	NULL
,	NULL
2	NULL
,	NULL
4	NULL
,	NULL
and	NULL
6	NULL
h	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Autoradiographs	NULL
exposed	NULL
for	NULL
different	NULL
times	NULL
were	NULL
scanned	NULL
in	NULL
a	NULL
densitometer	NULL
(	NULL
UitroScan	NULL
XL	NULL
;	NULL
Pharma-cia	NULL
)	NULL
.	NULL

This	NULL
ensured	NULL
that	NULL
the	NULL
values	NULL
obtained	NULL
were	NULL
in	NULL
the	NULL
linear	NULL
range	NULL
of	NULL
response	NULL
of	NULL
densitometry	NULL
.	NULL

Acknowledgments	NULL
We	NULL
are	NULL
grateful	NULL
to	NULL
Giulia	NULL
Pacetto	NULL
and	NULL
Sabrina	NULL
Tocchio	NULL
for	NULL
typing	NULL
the	NULL
manuscript	NULL
,	NULL
to	NULL
Stefania	NULL
Mochi	NULL
for	NULL
oligonucleotide	NULL
synthesis	NULL
,	NULL
and	NULL
to	NULL
Dr.	NULL
Corrado	NULL
Baglioni	NULL
for	NULL
helpful	NULL
discussions	NULL
and	NULL
suggestions	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Basuerie	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

The	NULL
inducible	NULL
transcription	NULL
activator	NULL
NF-kB	NULL
:	NULL
regulation	NULL
by	NULL
distinct	NULL
protein	NULL
subunits	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
,	NULL
1072	NULL
;	NULL
63-69	NULL
,	NULL
1991	NULL
.	NULL

2	NULL
.	NULL

Grill	NULL
,	NULL
M.	NULL
,	NULL
Chiu	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
and	NULL
Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Rel-participants	NULL
in	NULL
a	NULL
multiform	NULL
transcriptional	NULL
regulatory	NULL
system	NULL
.	NULL

Int	NULL
.	NULL

Rev	NULL
.	NULL

Cytol	NULL
.	NULL

,	NULL
143	NULL
:	NULL
1-62	NULL
,	NULL
1993	NULL
.	NULL

3	NULL
.	NULL

Liou	NULL
,	NULL
H.	NULL
C.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
Regulation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Rel	NULL
transcription	NULL
factor	NULL
and	NULL
I	NULL
«	NULL
B	NULL
inhibitor	NULL
system	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

,	NULL
5	NULL
:	NULL
477-487	NULL
,	NULL
1993	NULL
.	NULL

4	NULL
.	NULL

Gilmore	NULL
,	NULL
T.	NULL
D.	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
KBF1	NULL
.	NULL

Dorsal	NULL
and	NULL
related	NULL
matters	NULL
.	NULL

Cell	NULL
,	NULL
62	NULL
:	NULL
841-843	NULL
,	NULL
1990	NULL
.	NULL

5	NULL
.	NULL

Schmitz	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
Baguerte	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

The	NULL
p65	NULL
subunit	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
strong	NULL
transcription	NULL
activating	NULL
potential	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
10	NULL
:	NULL
3805-3817	NULL
,	NULL
1991	NULL
.	NULL

6	NULL
.	NULL

Basuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
A	NULL
65	NULL
kD	NULL
subunit	NULL
of	NULL
active	NULL
NF-kB	NULL
is	NULL
required	NULL
for	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
IxB	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
3	NULL
:	NULL
1689-1698	NULL
,	NULL
1989	NULL
.	NULL

7	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr	NULL
.	NULL

The	NULL
IB	NULL
proteins	NULL
:	NULL
multifunctional	NULL
regulators	NULL
of	NULL
ReVNF-	NULL
«	NULL
B	NULL
transcription	NULL
factors	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
7	NULL
:	NULL
2064-2070	NULL
,	NULL
1994	NULL
.	NULL

8	NULL
.	NULL

Emst	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
Dunn	NULL
,	NULL
L.	NULL
L.	NULL
,	NULL
and	NULL
Rice	NULL
,	NULL
N.	NULL
R.	NULL
The	NULL
PEST-like	NULL
sequence	NULL
of	NULL
IkBa	NULL
is	NULL
responsible	NULL
for	NULL
inhibition	NULL
of	NULL
DNA	NULL
binding	NULL
but	NULL
not	NULL
for	NULL
cytoplasmic	NULL
retention	NULL
of	NULL
c-Ret	NULL
or	NULL
RelA	NULL
homodimers	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
15	NULL
:	NULL
872-882	NULL
,	NULL
1995	NULL
.	NULL

9	NULL
.	NULL

Haskill	NULL
,	NULL
S.	NULL
,	NULL
Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Tompkins	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Moris	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Yurochko	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Sampson-Johannes	NULL
,	NULL
A.	NULL
,	NULL
Mondal	NULL
,	NULL
K.	NULL
,	NULL
Ralph	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr	NULL
.	NULL

Characterization	NULL
of	NULL
an	NULL
immediate-early	NULL
gene	NULL
induced	NULL
in	NULL
adherent	NULL
monocytes	NULL
that	NULL
encodes	NULL
I	NULL
«	NULL
B-like	NULL
activity	NULL
.	NULL

Cell	NULL
,	NULL
65	NULL
:	NULL
1281-1289	NULL
,	NULL
1991	NULL
.	NULL

10	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Scheinman	NULL
,	NULL
R.	NULL
I.	NULL
,	NULL
Haskill	NULL
,	NULL
S.	NULL
,	NULL
Rosen	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
IxB	NULL
interacts	NULL
with	NULL
the	NULL
nuclear	NULL
localization	NULL
sequences	NULL
of	NULL
the	NULL
subunits	NULL
of	NULL
NF-xB	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
cytoplasmic	NULL
retention	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
6	NULL
:	NULL
1899-1913	NULL
,	NULL
1992	NULL
.	NULL

11	NULL
.	NULL

Ghosh	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Baitimore	NULL
,	NULL
D.	NULL
Activation	NULL
in	NULL
vitro	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
phosphorylation	NULL
of	NULL
its	NULL
inhibitor	NULL
IxB	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
344	NULL
:	NULL
678-682	NULL
,	NULL
1990	NULL
.	NULL

12	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
,	NULL
Gerstberger	NULL
,	NULL
S.	NULL
,	NULL
Carlson	NULL
,	NULL
L.	NULL
,	NULL
Franzoso	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

Control	NULL
of	NULL
IxBa	NULL
proteolysis	NULL
by	NULL
site-specific	NULL
,	NULL
signal-induced	NULL
phosphorylation	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
267	NULL
:	NULL
1485-1488	NULL
,	NULL
1995	NULL
.	NULL

13	NULL
.	NULL

Alkalay	NULL
,	NULL
I.	NULL
,	NULL
Yaron	NULL
,	NULL
A.	NULL
,	NULL
Hatzubai	NULL
,	NULL
A.	NULL
,	NULL
Jung	NULL
,	NULL
S.	NULL
,	NULL
Avraham	NULL
,	NULL
A.	NULL
,	NULL
Gerlitz	NULL
,	NULL
O.	NULL
,	NULL
Pashut-Lavon	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Ben-Neriah	NULL
,	NULL
Y.	NULL
in	NULL
vivo	NULL
stimulation	NULL
of	NULL
I	NULL
«	NULL
B	NULL
phosphorylation	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
activate	NULL
NF-xB	NULL
.	NULL

Mol	NULL
.	NULL

Celt	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
15	NULL
:	NULL
1294-1301	NULL
,	NULL
1995	NULL
.	NULL

14	NULL
.	NULL

Finco	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
Inducible	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
its	NULL
dissociation	NULL
from	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
is	NULL
inhibited	NULL
by	NULL
protease	NULL
inhibitors	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
91	NULL
:	NULL
11884-11888	NULL
,	NULL
1994	NULL
.	NULL

15	NULL
.	NULL

Chiao	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Miyamoto	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
Autoregulation	NULL
of	NULL
I	NULL
«	NULL
Ba	NULL
«	NULL
activity	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
91	NULL
:	NULL
28-32	NULL
,	NULL
1994	NULL
.	NULL

16	NULL
.	NULL

Le	NULL
Bail	NULL
,	NULL
O.	NULL
,	NULL
Schmidt-Ullrich	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Isradl	NULL
,	NULL
A	NULL
.	NULL

Promoter	NULL
analysis	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
IxBa/MAD-3	NULL
inhibitor	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
positive	NULL
regulation	NULL
by	NULL
members	NULL
of	NULL
the	NULL
reVNF-	NULL
«	NULL
B	NULL
family	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
12	NULL
:	NULL
5043-5049	NULL
,	NULL
1993	NULL
.	NULL

17	NULL
.	NULL

Sun	NULL
,	NULL
S.	NULL
,	NULL
Ganchi	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
NF-	NULL
«	NULL
B	NULL
controls	NULL
expression	NULL
of	NULL
inhibitor	NULL
IxB-a	NULL
:	NULL
evidence	NULL
for	NULL
an	NULL
inducible	NULL
autoreg-ulatory	NULL
pathway	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
259	NULL
:	NULL
1912-1915	NULL
,	NULL
1993	NULL
.	NULL

18	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
,	NULL
Park	NULL
,	NULL
S.	NULL
,	NULL
Kanno	NULL
,	NULL
T.	NULL
,	NULL
Franzoso	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

Mutual	NULL
regulation	NULL
of	NULL
the	NULL
transcriptional	NULL
activator	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
its	NULL
inhibitor	NULL
,	NULL
IxB-a	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
90	NULL
:	NULL
2532-2536	NULL
,	NULL
1993	NULL
.	NULL

19	NULL
.	NULL

Beaupariant	NULL
,	NULL
P.	NULL
,	NULL
Kwan	NULL
,	NULL
I.	NULL
,	NULL
Bitar	NULL
,	NULL
R.	NULL
,	NULL
Chou	NULL
,	NULL
P.	NULL
,	NULL
Koromilas	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
Sonenberg	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Hiscott	NULL
,	NULL
J.	NULL
Disruption	NULL
of	NULL
IBa	NULL
regulation	NULL
by	NULL
antisense	NULL
RNA	NULL
expression	NULL
leads	NULL
to	NULL
malignant	NULL
transformation	NULL
.	NULL

Oncogene	NULL
,	NULL
9	NULL
:	NULL
3189-3197	NULL
,	NULL
1994	NULL
.	NULL

20	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
Multiple	NULL
nuclear	NULL
factors	NULL
interact	NULL
with	NULL
the	NULL
immunoglobulin	NULL
enhancer	NULL
sequences	NULL
.	NULL

Cell	NULL
,	NULL
46	NULL
:	NULL
705-716	NULL
,	NULL
1986	NULL
.	NULL

21	NULL
.	NULL

Griffin	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
Leung	NULL
,	NULL
K.	NULL
,	NULL
Folks	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
Kunkel	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Nabel	NULL
,	NULL
G.	NULL
J.	NULL
Activation	NULL
of	NULL
HIV	NULL
gene	NULL
expression	NULL
during	NULL
monocyte	NULL
differentiation	NULL
by	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
339	NULL
:	NULL
70-73	NULL
,	NULL
1989	NULL
.	NULL

22	NULL
.	NULL

Frankenberger	NULL
,	NULL
M.	NULL
,	NULL
Pforte	NULL
,	NULL
A.	NULL
,	NULL
Stemmdorf	NULL
,	NULL
T.	NULL
,	NULL
Passlick	NULL
,	NULL
B.	NULL
,	NULL
Baeuerie	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Ziegler-Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
L.	NULL
Constitutive	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
monocyte	NULL
lineage	NULL
.	NULL

Biochem	NULL
.	NULL

J.	NULL
,	NULL
304	NULL
:	NULL
87-94	NULL
,	NULL
1994	NULL
.	NULL

23	NULL
.	NULL

Lofquist	NULL
,	NULL
A.	NULL
K.	NULL
,	NULL
Mondal	NULL
,	NULL
K.	NULL
,	NULL
Morris	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
and	NULL
Haskill	NULL
,	NULL
J.	NULL
S.	NULL
Transcrip-tion-independent	NULL
turnover	NULL
of	NULL
ixBa/MAD-3	NULL
mRNA	NULL
levels	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
15	NULL
:	NULL
1737-1746	NULL
,	NULL
1995	NULL
.	NULL

24	NULL
.	NULL

Oeth	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Parry	NULL
,	NULL
G.	NULL
C.	NULL
N.	NULL
,	NULL
Kunsch	NULL
,	NULL
C.	NULL
,	NULL
Nantermet	NULL
,	NULL
P.	NULL
,	NULL
Rosen	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
Mackman	NULL
,	NULL
N.	NULL
Lipopolysaccharide	NULL
induction	NULL
of	NULL
tissue	NULL
factor	NULL
gene	NULL
expression	NULL
in	NULL
monocytic	NULL
cells	NULL
is	NULL
mediated	NULL
by	NULL
binding	NULL
of	NULL
c-Rel/p65	NULL
heterodimers	NULL
to	NULL
a	NULL
xB-like	NULL
site	NULL
,	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
14	NULL
:	NULL
3772-3781	NULL
,	NULL
1994	NULL
.	NULL

441	NULL
442	NULL
-	NULL
NF-	NULL
«	NULL
B	NULL
Expression	NULL
in	NULL
Differentiating	NULL
Monocytes	NULL
25	NULL
.	NULL

Suzan	NULL
,	NULL
M.	NULL
,	NULL
Salaun	NULL
,	NULL
D.	NULL
,	NULL
Neuvent	NULL
,	NULL
C.	NULL
,	NULL
Spire	NULL
,	NULL
B.	NULL
,	NULL
Hirsch	NULL
,	NULL
I.	NULL
,	NULL
Le	NULL
Bouteiller	NULL
,	NULL
P.	NULL
,	NULL
Querat	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Sire	NULL
,	NULL
J	NULL
.	NULL

Induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
during	NULL
monocyte	NULL
differentiation	NULL
by	NULL
HIV	NULL
type	NULL
1	NULL
infection	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
146	NULL
:	NULL
377-383	NULL
,	NULL
1991	NULL
.	NULL

26	NULL
.	NULL

Roulston	NULL
,	NULL
A.	NULL
,	NULL
D'Addario	NULL
,	NULL
M.	NULL
,	NULL
Boulerice	NULL
,	NULL
F.	NULL
,	NULL
Caplan	NULL
,	NULL
S.	NULL
,	NULL
Wainberg	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
Hiscott	NULL
,	NULL
J	NULL
.	NULL

Induction	NULL
of	NULL
monocytic	NULL
differentiation	NULL
and	NULL
NF-xB-like	NULL
activities	NULL
by	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
1	NULL
infection	NULL
of	NULL
myelomonoblastic	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
175	NULL
:	NULL
751-763	NULL
,	NULL
1992	NULL
.	NULL

27	NULL
.	NULL

Kaufman	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Weinberg	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Greene	NULL
,	NULL
W.	NULL
C.	NULL
Nuclear	NULL
expression	NULL
of	NULL
the	NULL
50-	NULL
and	NULL
65	NULL
kD	NULL
Rel-related	NULL
subunits	NULL
of	NULL
nuclear	NULL
factor-	NULL
«	NULL
B	NULL
is	NULL
differentially	NULL
regulated	NULL
in	NULL
human	NULL
monocytic	NULL
cells	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
90	NULL
:	NULL
121-129	NULL
,	NULL
1992	NULL
.	NULL

28	NULL
.	NULL

Roulston	NULL
,	NULL
A.	NULL
,	NULL
Beauparlant	NULL
,	NULL
P.	NULL
,	NULL
Rice	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
and	NULL
Hiscott	NULL
,	NULL
J	NULL
.	NULL

Chronic	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
infection	NULL
stimulates	NULL
distinct	NULL
NF-	NULL
«	NULL
B/re	NULL
!	NULL

DNA	NULL
binding	NULL
activities	NULL
in	NULL
myelomonoblastic	NULL
cells	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
67	NULL
:	NULL
5235-5246	NULL
,	NULL
1993	NULL
.	NULL

29	NULL
.	NULL

Andreesen	NULL
,	NULL
R.	NULL
,	NULL
Osterholz	NULL
,	NULL
J.	NULL
,	NULL
Bodemann	NULL
,	NULL
H.	NULL
,	NULL
Bross	NULL
,	NULL
K.	NULL
,	NULL
Costabel	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Lohr	NULL
,	NULL
G.	NULL
Expression	NULL
of	NULL
transferrin	NULL
receptors	NULL
and	NULL
intracellular	NULL
ferritin	NULL
during	NULL
terminal	NULL
differentiation	NULL
of	NULL
human	NULL
monocytes	NULL
.	NULL

Blut	NULL
,	NULL
49	NULL
:	NULL
195-201	NULL
,	NULL
1984	NULL
.	NULL

30	NULL
.	NULL

Testa	NULL
,	NULL
U.	NULL
,	NULL
Conti	NULL
,	NULL
L.	NULL
,	NULL
Sposi	NULL
,	NULL
N.	NULL
M.	NULL
,	NULL
Varano	NULL
,	NULL
B.	NULL
,	NULL
Tritarelli	NULL
,	NULL
E.	NULL
,	NULL
Malorni	NULL
,	NULL
W.	NULL
,	NULL
Samoggia	NULL
,	NULL
P.	NULL
,	NULL
Rainaldi	NULL
,	NULL
G.	NULL
,	NULL
Peschle	NULL
,	NULL
C.	NULL
,	NULL
Belardelli	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Gessani	NULL
,	NULL
S.	NULL
IFN-B	NULL
selectively	NULL
down-regulates	NULL
transferrin	NULL
receptor	NULL
expression	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
macrophages	NULL
by	NULL
a	NULL
post-translational	NULL
mechanism	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
155	NULL
:	NULL
427-435	NULL
,	NULL
1995	NULL
.	NULL

31	NULL
.	NULL

Gessani	NULL
,	NULL
S.	NULL
,	NULL
Testa	NULL
,	NULL
U.	NULL
,	NULL
Varano	NULL
,	NULL
8.	NULL
,	NULL
Di	NULL
Marzio	NULL
,	NULL
P.	NULL
,	NULL
Borghi	NULL
,	NULL
P.	NULL
,	NULL
Conti	NULL
,	NULL
L.	NULL
,	NULL
Barberi	NULL
,	NULL
T.	NULL
,	NULL
Tritarelli	NULL
,	NULL
E.	NULL
,	NULL
Martucci	NULL
,	NULL
R.	NULL
,	NULL
Seripa	NULL
,	NULL
D.	NULL
,	NULL
Peschle	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Belardelli	NULL
,	NULL
F.	NULL
Enhanced	NULL
production	NULL
of	NULL
LPS-induced	NULL
cytokines	NULL
during	NULL
differentiation	NULL
of	NULL
human	NULL
monocytes	NULL
to	NULL
macrophages	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
157	NULL
:	NULL
3758-3766	NULL
,	NULL
1993	NULL
.	NULL

32	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Finco	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
Nantermet	NULL
,	NULL
P.	NULL
V.	NULL
,	NULL
and	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
Tumor	NULL
necrosis	NULL
factor	NULL
and	NULL
interleukin-1	NULL
lead	NULL
to	NULL
phosphorylation	NULL
and	NULL
loss	NULL
of	NULL
IxBa	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
13	NULL
:	NULL
3301-3310	NULL
,	NULL
1993	NULL
.	NULL

33	NULL
.	NULL

Franzoso	NULL
,	NULL
G.	NULL
,	NULL
Biswas	NULL
,	NULL
P.	NULL
,	NULL
Poli	NULL
,	NULL
G.	NULL
,	NULL
Carlson	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Brown	NULL
,	NULL
K.	NULL
D.	NULL
,	NULL
Yamaguchi	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
Fauci	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
and	NULL
Siebenlist	NULL
,	NULL
U.	NULL
K.	NULL
A	NULL
family	NULL
of	NULL
serine	NULL
proteases	NULL
expressed	NULL
exclusively	NULL
in	NULL
myelo-monocytic	NULL
cells	NULL
specifically	NULL
processes	NULL
the	NULL
nuclear	NULL
factor-	NULL
«	NULL
B	NULL
subunit	NULL
p65	NULL
in	NULL
vifro	NULL
and	NULL
may	NULL
impair	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
replication	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
180	NULL
:	NULL
1445-1456	NULL
,	NULL
1994	NULL
.	NULL

34	NULL
.	NULL

DiDonato	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Mercurio	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
Phosphorylation	NULL
of	NULL
IkBa	NULL
precedes	NULL
but	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
its	NULL
dissociation	NULL
from	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
15	NULL
:	NULL
1302-1311	NULL
,	NULL
1995	NULL
.	NULL

35	NULL
.	NULL

Henkel	NULL
,	NULL
T.	NULL
,	NULL
Machieidt	NULL
,	NULL
T.	NULL
,	NULL
Alkalay	NULL
,	NULL
I.	NULL
,	NULL
Kronke	NULL
,	NULL
M.	NULL
,	NULL
Ben-Neriah	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Basuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

Rapid	NULL
proteolysis	NULL
of	NULL
IkB-a	NULL
is	NULL
necessary	NULL
for	NULL
activation	NULL
of	NULL
transcription	NULL
factor	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
365	NULL
:	NULL
182-185	NULL
,	NULL
1993	NULL
.	NULL

36	NULL
.	NULL

Lin	NULL
,	NULL
Y.	NULL
C.	NULL
,	NULL
Brown	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Siebenlist	NULL
,	NULL
U.	NULL
Activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
requires	NULL
proteolysis	NULL
of	NULL
the	NULL
inhibitor	NULL
IxB-a	NULL
:	NULL
signal-induced	NULL
phosphorylation	NULL
of	NULL
IB-	NULL
«	NULL
alone	NULL
does	NULL
not	NULL
release	NULL
active	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
92	NULL
:	NULL
552-556	NULL
,	NULL
1995	NULL
.	NULL

37	NULL
.	NULL

Palombella	NULL
,	NULL
V.	NULL
J.	NULL
,	NULL
Rando	NULL
,	NULL
O.	NULL
J.	NULL
,	NULL
Goldberg	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
The	NULL
ubiquitin-proteasome	NULL
pathway	NULL
is	NULL
required	NULL
for	NULL
processing	NULL
the	NULL
NF-	NULL
«	NULL
B1	NULL
precursor	NULL
protein	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Cell	NULL
,	NULL
78	NULL
:	NULL
773-785	NULL
,	NULL
1994	NULL
.	NULL

38	NULL
.	NULL

Traenckner	NULL
,	NULL
E.	NULL
B.	NULL
M.	NULL
,	NULL
Wilk	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Baeuerle	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

A	NULL
proteasome	NULL
inhibitor	NULL
prevents	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
stabilizes	NULL
a	NULL
newly	NULL
phosphorylated	NULL
form	NULL
of	NULL
I	NULL
«	NULL
Ba	NULL
that	NULL
is	NULL
still	NULL
bound	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
13	NULL
:	NULL
5433-5441	NULL
,	NULL
1994	NULL
.	NULL

39	NULL
.	NULL

Imbert	NULL
,	NULL
V.	NULL
,	NULL
Rupec	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Livolsi	NULL
,	NULL
A.	NULL
,	NULL
Pahl	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
Traenckner	NULL
,	NULL
E.	NULL
B.	NULL
M.	NULL
,	NULL
Mueller-Dieckmann	NULL
,	NULL
C.	NULL
,	NULL
Farahifar	NULL
,	NULL
D.	NULL
,	NULL
Rossi	NULL
,	NULL
B.	NULL
,	NULL
Auberger	NULL
,	NULL
P.	NULL
,	NULL
Baeuerie	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Peyron	NULL
,	NULL
J-F.	NULL
Tyrosine	NULL
phosphorylation	NULL
of	NULL
IxB-a	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
without	NULL
proteolytic	NULL
degradation	NULL
of	NULL
IkB-a	NULL
.	NULL

Cell	NULL
,	NULL
86	NULL
:	NULL
787-798	NULL
,	NULL
1996	NULL
.	NULL

40	NULL
.	NULL

Narayanan	NULL
,	NULL
R.	NULL
,	NULL
Higgins	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Coleman	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Lawlor	NULL
,	NULL
K.	NULL
G.	NULL
,	NULL
and	NULL
Rosen	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

Evidence	NULL
for	NULL
differential	NULL
functions	NULL
of	NULL
p50	NULL
and	NULL
p6§5	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
using	NULL
a	NULL
cell	NULL
adhesion	NULL
model	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
13	NULL
:	NULL
3802-3810	NULL
,	NULL
1993	NULL
.	NULL

41	NULL
.	NULL

Hickstein	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
Back	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
and	NULL
Collins	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
CD11b	NULL
and	NULL
CD18	NULL
subunits	NULL
of	NULL
the	NULL
neutrophil	NULL
adherence	NULL
receptor	NULL
during	NULL
human	NULL
myeloid	NULL
differentiation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
264	NULL
:	NULL
21812-21821	NULL
,	NULL
1989	NULL
.	NULL

42	NULL
.	NULL

Bachelerie	NULL
,	NULL
F.	NULL
,	NULL
Alcami	NULL
,	NULL
J.	NULL
,	NULL
Arenzana-Seisdedos	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Virilizier	NULL
,	NULL
J.	NULL
L.	NULL
HIV	NULL
enhancer	NULL
activity	NULL
perpetuated	NULL
by	NULL
NF-kB	NULL
induction	NULL
on	NULL
infection	NULL
of	NULL
monocytes	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
350	NULL
:	NULL
709-712	NULL
,	NULL
1991	NULL
.	NULL

43	NULL
.	NULL

Nabel	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
An	NULL
inducible	NULL
transcription	NULL
factor	NULL
activates	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
350	NULL
:	NULL
711-713	NULL
,	NULL
1987	NULL
.	NULL

44	NULL
.	NULL

Rich	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Chen	NULL
,	NULL
I.	NULL
S.	NULL
Y.	NULL
,	NULL
Zack	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Leonard	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
O'Brien	NULL
,	NULL
W.	NULL
A	NULL
.	NULL

Increased	NULL
susceptibility	NULL
of	NULL
differentiated	NULL
mononuclear	NULL
phagocytes	NULL
to	NULL
productive	NULL
infection	NULL
with	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
89	NULL
:	NULL
176-183	NULL
,	NULL
1992	NULL
.	NULL

45	NULL
.	NULL

Gessani	NULL
,	NULL
S.	NULL
,	NULL
Puddu	NULL
,	NULL
P.	NULL
,	NULL
Varano	NULL
,	NULL
B.	NULL
,	NULL
Borghi	NULL
,	NULL
P.	NULL
,	NULL
Conti	NULL
,	NULL
L.	NULL
,	NULL
Fantuzzi	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Belardelli	NULL
,	NULL
F.	NULL
Induction	NULL
of	NULL
8	NULL
interferon	NULL
by	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
and	NULL
its	NULL
gp120	NULL
protein	NULL
in	NULL
human	NULL
monocytes-macrophages	NULL
.	NULL

Role	NULL
of	NULL
8	NULL
interferon	NULL
in	NULL
the	NULL
restriction	NULL
of	NULL
virus	NULL
replication	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
68	NULL
:	NULL
1983-1986	NULL
,	NULL
1994	NULL
.	NULL

46	NULL
.	NULL

Osbom	NULL
,	NULL
L.	NULL
,	NULL
Kunkel	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Nabel	NULL
,	NULL
G.	NULL
J.	NULL
Tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
and	NULL
interleukin	NULL
1	NULL
stimulate	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
enhancer	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
86	NULL
:	NULL
2336-2340	NULL
,	NULL
1989	NULL
.	NULL

47	NULL
.	NULL

Lacoste	NULL
,	NULL
J.	NULL
,	NULL
D'Addario	NULL
,	NULL
M.	NULL
,	NULL
Roulston	NULL
,	NULL
A.	NULL
,	NULL
Wainberg	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
Hiscott	NULL
,	NULL
J.	NULL
Cell-specific	NULL
differences	NULL
in	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
regulatory	NULL
elements	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
and	NULL
8	NULL
interferon	NULL
promoters	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
64	NULL
:	NULL
4726-4734	NULL
,	NULL
1990	NULL
.	NULL

48	NULL
.	NULL

Pepin	NULL
,	NULL
N.	NULL
,	NULL
Roulston	NULL
,	NULL
A.	NULL
,	NULL
Lacoste	NULL
,	NULL
J.	NULL
,	NULL
Lin	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Hiscott	NULL
,	NULL
J.	NULL
Subcellular	NULL
distribution	NULL
of	NULL
HTLV-1	NULL
Tax	NULL
protein	NULL
by	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
.	NULL

Virology	NULL
,	NULL
204	NULL
:	NULL
706-715	NULL
,	NULL
1994	NULL
.	NULL

49	NULL
.	NULL

Di	NULL
Marzio	NULL
,	NULL
P.	NULL
,	NULL
Puddu	NULL
,	NULL
P.	NULL
,	NULL
Conti	NULL
,	NULL
L.	NULL
,	NULL
Belardelli	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Gessani	NULL
,	NULL
S.	NULL
Interferon	NULL
y	NULL
upregulates	NULL
its	NULL
own	NULL
gene	NULL
expression	NULL
in	NULL
mouse	NULL
peritoneal	NULL
macrophages	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
179	NULL
;	NULL
1731-1736	NULL
,	NULL
1994	NULL
.	NULL

50	NULL
.	NULL

Sokoloski	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Sartorelli	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Rosen	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
and	NULL
Narayanan	NULL
,	NULL
R.	NULL
Antisense	NULL
oligonucleotides	NULL
to	NULL
the	NULL
p65	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
block	NULL
CD11b	NULL
expression	NULL
and	NULL
alter	NULL
adhesion	NULL
properties	NULL
of	NULL
differentiated	NULL
HL-60	NULL
granu-locytes	NULL
.	NULL

Blood	NULL
,	NULL
82	NULL
:	NULL
625-632	NULL
,	NULL
1993	NULL
.	NULL

